Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cell-cell adhesion mediator activity	CNTN6 CNTN5 IGSF9 ROBO4 ANXA2 PALLD	6.99e-05	61	229	6	GO:0098632
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	GBF1 DOCK11 OBSCN FGD4 IQSEC1 HERC2 ALS2 PLEKHG6 RAB3IP ITSN2 DOCK7	7.68e-05	231	229	11	GO:0005085
GeneOntologyMolecularFunction	phosphatidylserine transfer activity	OSBPL5 OSBPL8	1.31e-04	2	229	2	GO:0140343
GeneOntologyMolecularFunction	bone sialoprotein binding	ANXA2 ANXA2P2	1.31e-04	2	229	2	GO:0044730
GeneOntologyMolecularFunction	cell adhesion mediator activity	CNTN6 CNTN5 IGSF9 ROBO4 ANXA2 PALLD	2.39e-04	76	229	6	GO:0098631
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CADM3 KLF4 CNTN6 FAT2 CNTN5 PCDH19 PKD1 IGSF9 ROBO4 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7 TENM4 ARVCF TENM1 PALLD	2.21e-09	313	228	19	GO:0098742
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CADM3 CNTN6 FAT2 CNTN5 PCDH19 PKD1 IGSF9 ROBO4 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7 PALLD	2.72e-09	187	228	15	GO:0007156
GeneOntologyBiologicalProcess	neuron development	EPHB3 TANC2 MAP1A SRF NCK1 KLF4 CNTN6 JUN PTPRZ1 CNTN5 IQSEC1 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B FAT4 LHX4 TNC CECR2 ALS2 FRYL SPAG9 LHX3 SEMA4G RNF220 LIMK1 IFRD1 TENM4 EGFR FEZF1 ZNF335 RP1L1 ITSN2 DOCK7 TENM1 PALLD EPHA10 MAPK8IP2 OTOG	8.82e-08	1463	228	40	GO:0048666
GeneOntologyBiologicalProcess	axon development	EPHB3 MAP1A SRF KLF4 CNTN6 JUN PTPRZ1 CNTN5 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B LHX4 TNC ALS2 LHX3 SEMA4G LIMK1 IFRD1 FEZF1 DOCK7 PALLD EPHA10	2.08e-07	642	228	24	GO:0061564
GeneOntologyBiologicalProcess	neuron projection development	EPHB3 TANC2 MAP1A SRF NCK1 KLF4 CNTN6 JUN PTPRZ1 CNTN5 IQSEC1 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B FAT4 LHX4 TNC CECR2 ALS2 FRYL SPAG9 LHX3 SEMA4G LIMK1 IFRD1 EGFR FEZF1 ZNF335 ITSN2 DOCK7 PALLD EPHA10 MAPK8IP2 OTOG	2.40e-07	1285	228	36	GO:0031175
GeneOntologyBiologicalProcess	neuron projection morphogenesis	EPHB3 TANC2 MAP1A SRF CNTN6 PTPRZ1 CNTN5 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B LHX4 ALS2 SPAG9 LHX3 SEMA4G LIMK1 IFRD1 EGFR FEZF1 ZNF335 ITSN2 DOCK7 PALLD EPHA10 MAPK8IP2	2.80e-07	802	228	27	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	EPHB3 TANC2 MAP1A SRF CNTN6 PTPRZ1 CNTN5 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B LHX4 ALS2 SPAG9 LHX3 SEMA4G LIMK1 IFRD1 EGFR FEZF1 ZNF335 ITSN2 DOCK7 PALLD EPHA10 MAPK8IP2	4.23e-07	819	228	27	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	EPHB3 TANC2 MAP1A SRF CNTN6 PTPRZ1 CNTN5 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B LHX4 ALS2 SPAG9 LHX3 SEMA4G LIMK1 IFRD1 EGFR FEZF1 ZNF335 ITSN2 DOCK7 PALLD EPHA10 MAPK8IP2	4.99e-07	826	228	27	GO:0048858
GeneOntologyBiologicalProcess	dendrite self-avoidance	CNTN6 CNTN5 IGSF9 ROBO4 PALLD	1.20e-06	18	228	5	GO:0070593
GeneOntologyBiologicalProcess	axonogenesis	EPHB3 MAP1A SRF CNTN6 PTPRZ1 CNTN5 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B LHX4 ALS2 LHX3 SEMA4G LIMK1 IFRD1 FEZF1 DOCK7 PALLD EPHA10	1.41e-06	566	228	21	GO:0007409
GeneOntologyBiologicalProcess	cell-cell adhesion	EPHB3 CADM3 IL12RB1 SRF NCK1 KLF4 CNTN6 JAK3 FAT2 CNTN5 PCDH19 PKD1 IGSF9 MEX3B ROBO4 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7 ANXA2 TENM4 EGFR ARVCF TENM1 MUC4 PALLD IL6ST SMAD7	3.06e-06	1077	228	30	GO:0098609
GeneOntologyBiologicalProcess	neuron recognition	EPHB3 CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 PALLD	3.85e-06	59	228	7	GO:0008038
GeneOntologyBiologicalProcess	cell morphogenesis	EPHB3 TANC2 MAP1A SRF CNTN6 FGD4 PTPRZ1 CNTN5 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B LHX4 LRATD1 ALS2 FRYL SPAG9 LHX3 SEMA4G LIMK1 IFRD1 EGFR FEZF1 EPHA2 ZNF335 ITSN2 DOCK7 PALLD EPHA10 MAPK8IP2	8.55e-06	1194	228	31	GO:0000902
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	EPHB3 TANC2 MAP1A SRF CNTN6 PTPRZ1 CNTN5 IGSF9 SEMA4F DIP2B ROBO4 SEMA4B LHX4 ALS2 LHX3 SEMA4G LIMK1 IFRD1 FEZF1 DOCK7 PALLD EPHA10 MAPK8IP2	1.00e-05	748	228	23	GO:0048667
GeneOntologyBiologicalProcess	axon guidance	EPHB3 CNTN6 CNTN5 IGSF9 SEMA4F ROBO4 SEMA4B LHX4 LHX3 SEMA4G FEZF1 PALLD EPHA10	1.85e-05	285	228	13	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	EPHB3 CNTN6 CNTN5 IGSF9 SEMA4F ROBO4 SEMA4B LHX4 LHX3 SEMA4G FEZF1 PALLD EPHA10	1.92e-05	286	228	13	GO:0097485
GeneOntologyBiologicalProcess	regulation of cell growth	CYP27B1 SRF JADE1 RPTOR IL17RB USP47 SEMA4F DIP2B TNC WFDC1 SPAG9 LIMK1 IFRD1 EGFR ITSN2 G6PD DCBLD2 SMAD7	2.03e-05	519	228	18	GO:0001558
GeneOntologyBiologicalProcess	phosphatidylserine acyl-chain remodeling	PLA1A OSBPL5 OSBPL8	1.07e-04	9	228	3	GO:0036150
GeneOntologyBiologicalProcess	positive regulation of low-density lipoprotein particle receptor binding	ANXA2 ANXA2P2	1.22e-04	2	228	2	GO:1905597
GeneOntologyBiologicalProcess	medial motor column neuron differentiation	LHX4 LHX3	1.22e-04	2	228	2	GO:0021526
GeneOntologyBiologicalProcess	regulation of growth	CYP27B1 NACA SRF JADE1 RPTOR HSF1 IL17RB USP47 SEMA4F DIP2B TNC WFDC1 SPAG9 LIMK1 IFRD1 EGFR ITSN2 G6PD DCBLD2 RAI1 SMAD7	1.55e-04	777	228	21	GO:0040008
GeneOntologyBiologicalProcess	regulation of neurogenesis	SRF PTPRZ1 SEMA4F DIP2B ANXA2 ANXA2P2 LIMK1 IFRD1 SIRT2 TENM4 EGFR FEZF1 ZNF335 VCAN DOCK7 IL6ST	2.09e-04	515	228	16	GO:0050767
GeneOntologyBiologicalProcess	cell growth	CYP27B1 SRF JADE1 RPTOR IL17RB USP47 SEMA4F DIP2B TNC WFDC1 SPAG9 LIMK1 IFRD1 EGFR ITSN2 G6PD DCBLD2 SMAD7	2.15e-04	625	228	18	GO:0016049
GeneOntologyBiologicalProcess	regulation of nervous system development	EPHB3 SRF PTPRZ1 IQSEC1 SEMA4F DIP2B ANXA2 ANXA2P2 LIMK1 IFRD1 SIRT2 TENM4 EGFR FEZF1 ZNF335 VCAN DOCK7 IL6ST	2.15e-04	625	228	18	GO:0051960
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	TANC2 MYF6 UPB1 SRF E2F7 CDK11A KLF4 HOXD1 PKD1 HSF1 FOXI1 CECR2 WNT9A GCM1 CHD8 RNF220 SETD2 EGFR EPHA2 ZNF335 ARMC5 PAX7 RAI2	2.68e-04	929	228	23	GO:0009792
GeneOntologyBiologicalProcess	negative regulation of thymocyte apoptotic process	PTCRA JAK3 RORC	3.51e-04	13	228	3	GO:0070244
GeneOntologyBiologicalProcess	positive regulation of receptor-mediated endocytosis involved in cholesterol transport	ANXA2 ANXA2P2	3.62e-04	3	228	2	GO:1905602
GeneOntologyBiologicalProcess	negative regulation of low-density lipoprotein particle receptor catabolic process	ANXA2 ANXA2P2	3.62e-04	3	228	2	GO:0032804
GeneOntologyBiologicalProcess	regulation of transcription by RNA polymerase III	RPTOR CHD8 SETD5 TENM1	4.10e-04	32	228	4	GO:0006359
GeneOntologyCellularComponent	chromatin	MYF6 ZBTB22 SRF E2F7 JADE1 GMEB2 KLF4 JUN HOXD1 UBR5 SUPT7L DLX4 HSF1 FOXF2 FOXI1 LHX4 BICRA CECR2 GCM1 E2F3 CHD8 LHX3 SIRT2 ZFHX4 BAZ2A SETD5 CHD5 RORC PAX7 SLX4 KDM4B SMAD7	1.89e-04	1480	230	32	GO:0000785
GeneOntologyCellularComponent	perisynaptic extracellular matrix	PTPRZ1 TNC VCAN	2.03e-04	11	230	3	GO:0098966
GeneOntologyCellularComponent	synapse-associated extracellular matrix	PTPRZ1 TNC VCAN	3.47e-04	13	230	3	GO:0099535
GeneOntologyCellularComponent	AnxA2-p11 complex	ANXA2 ANXA2P2	3.59e-04	3	230	2	GO:1990665
GeneOntologyCellularComponent	PCSK9-AnxA2 complex	ANXA2 ANXA2P2	3.59e-04	3	230	2	GO:1990667
GeneOntologyCellularComponent	basement membrane	FREM2 NID1 COL17A1 TNC ANXA2 ANXA2P2 FREM3	4.09e-04	122	230	7	GO:0005604
GeneOntologyCellularComponent	cell leading edge	GBF1 FGD4 PTPRZ1 NHS CDC42BPG ANXA2 ANXA2P2 ALS2 LIMK1 MTMR14 EGFR EPHA2 RAB3IP PALLD GABRA1	4.54e-04	500	230	15	GO:0031252
GeneOntologyCellularComponent	ruffle	FGD4 PTPRZ1 ANXA2 ANXA2P2 ALS2 MTMR14 EGFR EPHA2 PALLD	4.79e-04	206	230	9	GO:0001726
GeneOntologyCellularComponent	Schmidt-Lanterman incisure	ANXA2 ANXA2P2 SIRT2	7.98e-04	17	230	3	GO:0043220
GeneOntologyCellularComponent	transcription regulator complex	MYF6 HIVEP2 E2F7 KLF4 JUN TLE7 FOXF2 ANXA2 ANXA2P2 GCM1 E2F3 LHX3 GTF2H1 CHD5 PAX7 SMAD7	9.72e-04	596	230	16	GO:0005667
GeneOntologyCellularComponent	euchromatin	KLF4 JUN HSF1 CECR2 SETD5	1.19e-03	72	230	5	GO:0000791
Domain	FN3_dom	EPHB3 IL12RB1 OBSCN F3 CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 FLNC TNC EPHA2 IL6ST EPHA10	2.99e-07	209	228	14	IPR003961
Domain	FN3	EPHB3 IL12RB1 OBSCN CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 FLNC TNC EPHA2 IL6ST EPHA10	4.63e-07	185	228	13	SM00060
Domain	fn3	EPHB3 IL12RB1 OBSCN CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 TNC EPHA2 IL6ST EPHA10	7.36e-07	162	228	12	PF00041
Domain	Cadherin	FREM2 FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7 FREM3	1.86e-06	118	228	10	IPR002126
Domain	FN3	EPHB3 IL12RB1 OBSCN CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 TNC EPHA2 IL6ST EPHA10	6.33e-06	199	228	12	PS50853
Domain	CA	FREM2 FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.18e-05	115	228	9	SM00112
Domain	Cadherin_CS	FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	5.75e-05	109	228	8	IPR020894
Domain	PH_dom-like	DOCK11 OBSCN JAK3 FGD4 OSBPL5 IQSEC1 OSBPL8 CDC42BPG ALS2 GTF2H1 PLEKHG6 ITSN2 FRMPD3 TNS1 SNTA1 MAPK8IP2	7.32e-05	426	228	16	IPR011993
Domain	CADHERIN_1	FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	7.43e-05	113	228	8	PS00232
Domain	Cadherin	FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	7.43e-05	113	228	8	PF00028
Domain	ARM-type_fold	GBF1 DOCK11 URB1 RPTOR HEATR5B USP24 TOGARAM2 FRYL HUWE1 IFRD1 ARVCF ARMC5 SERAC1 PUM1	7.68e-05	339	228	14	IPR016024
Domain	CADHERIN_2	FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	7.91e-05	114	228	8	PS50268
Domain	-	FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	7.91e-05	114	228	8	2.60.40.60
Domain	Cadherin_tail	PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	8.22e-05	37	228	5	PF15974
Domain	Cadherin_CBD	PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	8.22e-05	37	228	5	IPR031904
Domain	Cadherin-like	FAT2 PCDH19 FAT4 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	8.94e-05	116	228	8	IPR015919
Domain	EGF-like_CS	BMP1 FAT2 MUC17 NID1 FAT4 TNC TENM4 EPHA2 VCAN TENM1 MUC4 EPHA10	9.19e-05	261	228	12	IPR013032
Domain	EGF_2	BMP1 FAT2 MUC17 NID1 FAT4 TNC TENM4 EPHA2 VCAN TENM1 MUC4 EPHA10	1.06e-04	265	228	12	PS01186
Domain	PHD	JADE1 PHF21B TCF20 BAZ2A CHD5 KDM4B RAI1	1.09e-04	89	228	7	SM00249
Domain	Znf_PHD	JADE1 PHF21B TCF20 BAZ2A CHD5 KDM4B RAI1	1.25e-04	91	228	7	IPR001965
Domain	EPHD	JADE1 TCF20 KDM4B RAI1	1.33e-04	22	228	4	PS51805
Domain	Cadherin_2	PCDH19 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.40e-04	65	228	6	PF08266
Domain	Cadherin_N	PCDH19 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.40e-04	65	228	6	IPR013164
Domain	EGF_3	BMP1 FAT2 MUC17 NID1 FAT4 TNC TENM4 VCAN TENM1 MUC4 OTOG	1.54e-04	235	228	11	PS50026
Domain	Ig-like_fold	EPHB3 CADM3 IL12RB1 PTCRA OBSCN F3 CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 SEMA4B FLNC TNC SEMA4G EPHA2 VCAN CEACAM16 PALLD IL6ST EPHA10	1.60e-04	706	228	21	IPR013783
Domain	ZF_PHD_2	JADE1 PHF21B TCF20 BAZ2A CHD5 KDM4B RAI1	1.64e-04	95	228	7	PS50016
Domain	ZF_PHD_1	JADE1 PHF21B TCF20 BAZ2A CHD5 KDM4B RAI1	1.75e-04	96	228	7	PS01359
Domain	PROTEIN_KINASE_TYR	EPHB3 OBSCN LMTK3 JAK3 EGFR EPHA2 EPHA10	1.86e-04	97	228	7	PS00109
Domain	-	EPHB3 CADM3 IL12RB1 PTCRA OBSCN F3 CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 FLNC TNC SEMA4G EPHA2 VCAN CEACAM16 PALLD IL6ST EPHA10	1.92e-04	663	228	20	2.60.40.10
Domain	6-blade_b-propeller_TolB-like	WRAP73 NID1 TENM4 TENM1 HHIPL1	2.37e-04	46	228	5	IPR011042
Domain	EGF-like_dom	BMP1 FAT2 MUC17 NID1 FAT4 TNC TENM4 VCAN TENM1 MUC4 OTOG	2.54e-04	249	228	11	IPR000742
Domain	-	EPHB3 HERC2 GUSB EPHA2 DCBLD2 EPHA10	2.67e-04	73	228	6	2.60.120.260
Domain	HECT	UBR5 HACE1 HERC2 HUWE1	3.04e-04	27	228	4	PF00632
Domain	HECTc	UBR5 HACE1 HERC2 HUWE1	3.04e-04	27	228	4	SM00119
Domain	HECT_dom	UBR5 HACE1 HERC2 HUWE1	3.04e-04	27	228	4	IPR000569
Domain	HECT	UBR5 HACE1 HERC2 HUWE1	3.04e-04	27	228	4	PS50237
Domain	Ago_hook	TNRC6B TNRC6C	4.42e-04	3	228	2	PF10427
Domain	BSD	BSDC1 GTF2H1	4.42e-04	3	228	2	PF03909
Domain	BSD	BSDC1 GTF2H1	4.42e-04	3	228	2	SM00751
Domain	BSD_dom	BSDC1 GTF2H1	4.42e-04	3	228	2	IPR005607
Domain	TNRC6_PABC-bd	TNRC6B TNRC6C	4.42e-04	3	228	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6B TNRC6C	4.42e-04	3	228	2	IPR019486
Domain	TNRC6-PABC_bdg	TNRC6B TNRC6C	4.42e-04	3	228	2	PF16608
Domain	BSD	BSDC1 GTF2H1	4.42e-04	3	228	2	PS50858
Domain	Znf_FYVE_PHD	JADE1 RBSN FGD4 PHF21B TCF20 BAZ2A CHD5 KDM4B	4.54e-04	147	228	8	IPR011011
Domain	RECEPTOR_TYR_KIN_V_2	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	PS00790
Domain	Tyr_kinase_rcpt_V_CS	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	IPR001426
Domain	EphA2_TM	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	PF14575
Domain	Ephrin_rcpt_lig-bd_dom	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	IPR001090
Domain	Eph_TM	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	IPR027936
Domain	EPH_lbd	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	SM00615
Domain	Ephrin_lbd	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	PF01404
Domain	Tyr_kinase_ephrin_rcpt	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	IPR016257
Domain	EPH_LBD	EPHB3 EPHA2 EPHA10	5.92e-04	14	228	3	PS51550
Domain	PH	DOCK11 OBSCN FGD4 OSBPL5 IQSEC1 OSBPL8 CDC42BPG ALS2 PLEKHG6 ITSN2 SNTA1	6.43e-04	278	228	11	SM00233
Domain	EGF	BMP1 FAT2 MUC17 NID1 FAT4 TNC TENM4 VCAN TENM1 MUC4	6.46e-04	235	228	10	SM00181
Domain	PH_DOMAIN	DOCK11 OBSCN FGD4 OSBPL5 IQSEC1 OSBPL8 CDC42BPG ALS2 PLEKHG6 ITSN2 SNTA1	6.62e-04	279	228	11	PS50003
Domain	PH_domain	DOCK11 OBSCN FGD4 OSBPL5 IQSEC1 OSBPL8 CDC42BPG ALS2 PLEKHG6 ITSN2 SNTA1	6.82e-04	280	228	11	IPR001849
Domain	-	KIF21B RPTOR WRAP73 SEMA4F SEMA4B GRWD1 SPAG9 NUP214 SEMA4G WDR91 KCTD3 DCAF4	8.40e-04	333	228	12	2.130.10.10
Domain	Tox-GHH_dom	TENM4 TENM1	8.76e-04	4	228	2	IPR028916
Domain	Tox-GHH	TENM4 TENM1	8.76e-04	4	228	2	PF15636
Domain	Ten_N	TENM4 TENM1	8.76e-04	4	228	2	IPR009471
Domain	Ten_N	TENM4 TENM1	8.76e-04	4	228	2	PF06484
Domain	TENEURIN_N	TENM4 TENM1	8.76e-04	4	228	2	PS51361
Domain	WD40/YVTN_repeat-like_dom	KIF21B RPTOR WRAP73 SEMA4F SEMA4B GRWD1 SPAG9 NUP214 SEMA4G WDR91 KCTD3 DCAF4	8.85e-04	335	228	12	IPR015943
Domain	VWF_type-D	MUC19 MUC4 OTOG	8.94e-04	16	228	3	IPR001846
Domain	VWFD	MUC19 MUC4 OTOG	8.94e-04	16	228	3	PS51233
Domain	AT_hook	CECR2 ZNF524 BAZ2A	8.94e-04	16	228	3	PF02178
Domain	VWD	MUC19 MUC4 OTOG	8.94e-04	16	228	3	SM00216
Domain	VWD	MUC19 MUC4 OTOG	8.94e-04	16	228	3	PF00094
Domain	Galactose-bd-like	EPHB3 HERC2 GUSB EPHA2 DCBLD2 EPHA10	1.03e-03	94	228	6	IPR008979
Domain	-	DOCK11 OBSCN FGD4 OSBPL5 IQSEC1 OSBPL8 CDC42BPG ALS2 GTF2H1 PLEKHG6 ITSN2 TNS1 MAPK8IP2	1.08e-03	391	228	13	2.30.29.30
Domain	EGF_1	BMP1 FAT2 MUC17 NID1 FAT4 TNC TENM4 VCAN TENM1 MUC4	1.20e-03	255	228	10	PS00022
Domain	Tyr_kinase_AS	EPHB3 OBSCN JAK3 EGFR EPHA2 EPHA10	1.22e-03	97	228	6	IPR008266
Domain	-	NID1 TENM4 TENM1 HHIPL1	1.27e-03	39	228	4	2.120.10.30
Domain	NIDO_dom	NID1 MUC4	1.45e-03	5	228	2	IPR003886
Domain	NIDO	NID1 MUC4	1.45e-03	5	228	2	SM00539
Domain	NIDO	NID1 MUC4	1.45e-03	5	228	2	PF06119
Domain	NIDO	NID1 MUC4	1.45e-03	5	228	2	PS51220
Domain	YD	TENM4 TENM1	1.45e-03	5	228	2	IPR006530
Domain	RhoGEF	OBSCN FGD4 ALS2 PLEKHG6 ITSN2	1.65e-03	70	228	5	PF00621
Domain	DH_2	OBSCN FGD4 ALS2 PLEKHG6 ITSN2	1.65e-03	70	228	5	PS50010
Domain	-	RPTOR HEATR5B TOGARAM2 FRYL IFRD1 ARVCF ARMC5 SERAC1 PUM1	1.67e-03	222	228	9	1.25.10.10
Domain	Cadherin_C	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.68e-03	42	228	4	IPR032455
Domain	Cadherin_C_2	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.68e-03	42	228	4	PF16492
Domain	Semaphorin	SEMA4F SEMA4B SEMA4G	1.76e-03	20	228	3	IPR027231
Domain	-	OBSCN FGD4 ALS2 PLEKHG6 ITSN2	1.76e-03	71	228	5	1.20.900.10
Domain	DH-domain	OBSCN FGD4 ALS2 PLEKHG6 ITSN2	1.76e-03	71	228	5	IPR000219
Domain	ARM-like	RPTOR HEATR5B TOGARAM2 FRYL HUWE1 IFRD1 ARVCF ARMC5 SERAC1 PUM1	1.84e-03	270	228	10	IPR011989
Domain	BRK	CHD9 CHD8	2.15e-03	6	228	2	SM00592
Domain	BRK_domain	CHD9 CHD8	2.15e-03	6	228	2	IPR006576
Domain	DUF3398	DOCK11 DOCK7	2.15e-03	6	228	2	PF11878
Domain	DOCK_C/D_N	DOCK11 DOCK7	2.15e-03	6	228	2	IPR021816
Domain	BRK	CHD9 CHD8	2.15e-03	6	228	2	PF07533
Domain	PHD	JADE1 PHF21B BAZ2A CHD5 KDM4B	2.24e-03	75	228	5	PF00628
Domain	-	UBR5 HERC2 ALS2	2.33e-03	22	228	3	2.130.10.30
Domain	UBA	NACA USP24 TNRC6C HUWE1	2.56e-03	47	228	4	PS50030
Domain	RCC1/BLIP-II	UBR5 HERC2 ALS2	2.65e-03	23	228	3	IPR009091
Domain	Anoct_dimer	ANO4 ANO7	2.99e-03	7	228	2	PF16178
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 HIVEP2 GBF1 PCNX3 OBSCN PEX6 JADE1 ZNF236 KLF4 JAK3 JUN URB1 WIZ NUAK1 RPTOR OSBPL5 PKD1 UNKL SNX15 HERC2 SEMA4F SEMA4B FLNC BICRA CHD8 FRYL NUP214 TNRC6C HUWE1 MED13L PKMYT1 SIRT2 MTMR14 ARVCF SETD5 ZNF335 CHD5 PUM1 RAI1 SMAD7	2.54e-18	1105	232	40	35748872
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	GBF1 TNRC6B HIC2 HEPH URB1 UBR5 OSBPL8 ALS2 CHD8 SPAG9 TNRC6C MED13L TENM4 CHD5 KDM4B	3.86e-11	225	232	15	12168954
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 KIF21B DOCK11 ZBTB22 TNRC6B ARMCX4 LMTK3 WIZ UBR5 RPTOR IQSEC1 HERC2 DIP2B TCF20 PRR36 CHD8 HUWE1 WDR91 ARVCF RAB3IP DOCK7 ADGRA1 FRMPD3 TNS1 MAPK8IP2 RAI1	1.87e-09	963	232	26	28671696
Pubmed	A census of human transcription factors: function, expression and evolution.	MYF6 HIVEP2 SRF E2F7 HIC2 GMEB2 ZNF236 KLF4 JUN HOXD1 UNKL DLX4 HSF1 FOXF2 FOXI1 LHX4 GCM1 E2F3 LHX3 ZNF524 ZNF35 ZFHX4 ZNF335 RORC PAX7	2.64e-09	908	232	25	19274049
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF21B NACA HIC2 JADE1 GMEB2 HEPH NUAK1 RBM27 RPTOR OSBPL5 IGSF9 CECR2 E2F3 CHD8 CHD5 HHIPL1 NUP93 KDM4B RAI1	3.58e-09	529	232	19	14621295
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	HIVEP2 GBF1 NACA WIZ UBR5 USP47 FLNC CHD8 HUWE1 DOCK7 CLSPN PUM1 MAPK8IP2	6.56e-09	232	232	13	25515538
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	LMTK3 OSBPL5 IQSEC1 UNKL HSF1 PHF21B SEMA4F TCF20 PERM1 MAGEE1 FEZF1 ANO7 MAPK8IP2	6.91e-09	233	232	13	37704626
Pubmed	Human transcription factor protein interaction networks.	NACA TNRC6B CDK11A HIC2 GMEB2 KLF4 JUN LARP4B WIZ RBM27 SUPT7L HERC2 FOXI1 LHX4 TCF20 BICRA GCM1 E2F3 CHD8 SPAG9 NUP214 LHX3 TNRC6C ZFHX4 CHD5 NUP93 PAX7 EMD PUM1 SLX4 RAI2	8.49e-09	1429	232	31	35140242
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TANC2 MAP1A PEX6 TNRC6B HIC2 LARP4B ZNF469 WIZ UBR5 RPTOR PCDH19 SUPT7L WRAP73 IQSEC1 BICRA CECR2 CHD9 C16orf96 CHD8 SETD2 GTF2H1 ZFHX4 BAZ2A SETD5 CHD5 CLSPN RAI1	9.10e-09	1116	232	27	31753913
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 HIVEP2 GBF1 DOCK11 RBSN RPTOR IQSEC1 OSBPL8 NHS MEX3B DIP2B TCF20 COBLL1 ALS2 FRYL LIMK1 IFRD1 DOCK7 NUP93 PUM1 PALLD CRTC2 OTOG	2.07e-08	861	232	23	36931259
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	GBF1 MAP1A LMTK3 LDLRAD3 LARP4B ZNF469 FHIP1A MEX3B FOXI1 BICRA NUP214 MAGEE1 CHD5 PAX7 CLSPN CRTC2	3.94e-08	430	232	16	35044719
Pubmed	Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.	EPHB3 NCK1 ANXA2 EGFR EPHA2 ITSN2 G6PD DCBLD2	3.99e-08	75	232	8	15951569
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	LARP4B URB1 UBR5 OSBPL8 HERC2 USP47 FLNC TCF20 USP24 CHD8 FRYL SPAG9 NUP214 HUWE1 BAZ2A DOCK7 NUP93 PUM1 RAI1	1.01e-07	653	232	19	22586326
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	MYF6 ZBTB22 SRF E2F7 GMEB2 KLF4 JUN HOXD1 DLX4 HSF1 FOXI1 LHX4 GCM1 E2F3 ZNF524 RORC PAX7	1.79e-07	544	232	17	28473536
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CPAMD8 HIVEP2 HEBP2 OBSCN SRF TNRC6B ZNF236 RPTOR OSBPL5 IGSF9 CDC42BPG DIP2B PCDHGB1 BICRA MACROD1 CHD9 E2F3 FRYL TNRC6C HUWE1 SNX29 IFRD1 EGFR SETD5 RAB3IP AADAT KDM4B RAI1 KLHL26	2.61e-07	1489	232	29	28611215
Pubmed	Inhibition of ANXA2 regulated by SRF attenuates the development of severe acute pancreatitis by inhibiting the NF-κB signaling pathway.	SRF ANXA2 ANXA2P2	2.93e-07	3	232	3	35900381
Pubmed	Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation.	ANXA2 ANXA2P2 EGFR	2.93e-07	3	232	3	23792445
Pubmed	Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II.	TNC ANXA2 ANXA2P2	2.93e-07	3	232	3	28857429
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TANC2 OBSCN ALS2 CHD8 TNRC6C HUWE1 MAGEE1 SEMA4G	4.12e-07	101	232	8	10997877
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	JPH4 JADE1 ZNF469 ADGRA1 HHIPL1 FRMPD3 SLX4 RAI1	6.42e-07	107	232	8	11347906
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNRC6B UBR5 PCDH19 TCF20 ALS2 NUP214 TNRC6C MED13L TENM4 BAZ2A SETD5 ITSN2 DOCK7 PUM1	7.25e-07	407	232	14	12693553
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	MAP1A UBR5 HERC2 USP47 FLNC TNRC6C HUWE1	7.94e-07	76	232	7	27542412
Pubmed	Annexin A2 is a Robo4 ligand that modulates ARF6 activation-associated cerebral trans-endothelial permeability.	ROBO4 ANXA2 ANXA2P2	1.17e-06	4	232	3	29786451
Pubmed	Noggin is required for correct guidance of dorsal root ganglion axons.	EPHB3 SEMA4F SEMA4B SEMA4G PAX7	1.32e-06	29	232	5	12435358
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	2.49e-06	15	232	4	23515096
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DOCK11 OBSCN HIC2 MAGEB6 FREM2 URB1 WIZ PKD1 CDC42BPG SEMA4F FAT4 MUC19 SPAG9 AMER3 HUWE1 PWWP3B EMD RAI1	2.63e-06	736	232	18	29676528
Pubmed	Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.	FREM2 NID1 FREM3	2.90e-06	5	232	3	17596926
Pubmed	Identification of a novel cell-adhesive protein spatiotemporally expressed in the basement membrane of mouse developing hair follicle.	FREM2 NID1 TNC FREM3	3.30e-06	16	232	4	15878328
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GBF1 CDK11A JUN RPTOR IQSEC1 HSF1 USP47 DIP2B TCF20 USP24 SPAG9 NUP214 HUWE1 SETD2 EGFR BAZ2A ZNF335 KDM4B	5.26e-06	774	232	18	15302935
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC19 MUC16 MUC4	5.49e-06	18	232	4	18834073
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	GBF1 RUNDC3B ZBTB22 SLCO3A1 HERC2 ROBO4 TNC MUC16 SNX29 MTMR14 EGFR EPHA2 EMD	5.72e-06	420	232	13	28065597
Pubmed	Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1.	F3 ANXA2 ANXA2P2	5.77e-06	6	232	3	18174463
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TANC2 GBF1 LARP4B FAT2 PER3 OSBPL8 MEX3B SEMA4B COBLL1 SPAG9 SEMA4G SETD2 PALLD SLX4	6.67e-06	493	232	14	15368895
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	DOCK11 TNRC6B NHS TNC ALS2 SLC7A2 ZNF335 PWWP3B EMD PUM1 TNS1 DCAF4	6.81e-06	363	232	12	14691545
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KIF21B DOCK11 OBSCN CDK11A OSBPL8 NID1 TOGARAM2 CHD9 NUP214 PUM1 MUC4 G6PD KDM4B RAI1	7.31e-06	497	232	14	36774506
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	GBF1 RUNDC3B PEX6 RBSN RPTOR OSBPL8 HEATR5B SNX29 PKMYT1 WDR91 SLC7A2 EPHA2 TENM1 EMD	8.55e-06	504	232	14	34432599
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	FAT2 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	8.93e-06	72	232	6	10380929
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	RBM27 RPTOR PCDH19 HACE1 IGSF9 HEATR5B TENM4 CHD5	9.37e-06	153	232	8	10718198
Pubmed	GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.	GBF1 IQSEC1 EGFR	1.01e-05	7	232	3	18084281
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	FAT2 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.32e-05	77	232	6	10835267
Pubmed	Defining the membrane proteome of NK cells.	GBF1 LARP4B UBR5 OSBPL5 IQSEC1 OSBPL8 HERC2 HEATR5B SLC27A3 DIP2B ANXA2 OAS2 HUWE1 PKMYT1 ACTR1B GUSB CHD5 NUP93 EMD G6PD GAA IL6ST	1.34e-05	1168	232	22	19946888
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	EPHB3 CADM3 IGSF9 SEMA4F SEMA4B SEMA4G DCBLD2	1.43e-05	117	232	7	17145500
Pubmed	Mapping homologs of Drosophila odd Oz (odz): Doc4/Odz4 to mouse chromosome 7, Odz1 to mouse chromosome 11; and ODZ3 to human chromosome Xq25.	TENM4 TENM1 GABRA1	1.60e-05	8	232	3	10331952
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	FAT2 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.64e-05	80	232	6	10716726
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	NACA E2F7 URB1 UBR5 ALDH1L2 HACE1 GRWD1 HUWE1 EMD	1.94e-05	221	232	9	29991511
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TNRC6B NCK1 WIZ RBM27 TCF20 ANXA2 USP24 CHD8 SPAG9 HUWE1 SETD2 BAZ2A DOCK7 PALLD	2.21e-05	549	232	14	38280479
Pubmed	The DNA sequence and biological annotation of human chromosome 1.	KIF21B CADM3 OBSCN CDK11A F3 JUN PER3 WRAP73 NID1 SLC27A3 WNT9A BSDC1 RNF220 CHD5 KCTD3 DOCK7 AGMAT PAX7 CLSPN PUM1	2.22e-05	1031	232	20	16710414
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TANC2 ARRDC1 LARP4B UBR5 RPTOR WRAP73 IQSEC1 HEATR5B USP47 GRWD1 TNRC6C WDR91 SETD2 SIRT2 MTMR14 KCTD3 DOCK7 CLSPN PUM1 CRTC2	2.44e-05	1038	232	20	26673895
Pubmed	System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.	UBR5 HACE1 HERC2 HUWE1	2.57e-05	26	232	4	26949039
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TANC2 CADM3 MAP1A NACA TNRC6B LARP4B RBSN HSPA12A RPTOR IQSEC1 OSBPL8 ANXA2 ANXA2P2 USP24 BSDC1 HUWE1 TENM4 DOCK7 TENM1 EMD GABRA1	2.89e-05	1139	232	21	36417873
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	GBF1 NCK1 UBR5 OSBPL8 NID1 USP47 SLC27A3 DIP2B FLNC SPAG9 NUP214 HUWE1 MTMR14 EPHA2 KCTD3 NUP93 EMD G6PD SNTA1	3.32e-05	974	232	19	28675297
Pubmed	Widespread neuronal ectopia associated with secondary defects in cerebrocortical chondroitin sulfate proteoglycans and basal lamina in MARCKS-deficient mice.	PTPRZ1 TNC VCAN	3.40e-05	10	232	3	9184108
Pubmed	Statistical analysis of the 5' untranslated region of human mRNA using "Oligo-Capped" cDNA libraries.	COL17A1 PPOX SLC7A2	3.40e-05	10	232	3	10756096
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	CNTN6 PCDH19 IGSF9 TENM4 TENM1 EPHA10	3.43e-05	91	232	6	28558017
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	3.48e-05	28	232	4	15347688
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TANC2 IL12RB1 MAP1A HSPA12A FGD4 PTPRZ1 RPTOR IQSEC1 OSBPL8 FLNC PRR36 TNC ANXA2 ANXA2P2 SIRT2 TENM4 ARVCF VCAN ITSN2 DOCK7 TNS1 ATP2B3 SNTA1 MAPK8IP2	3.52e-05	1431	232	24	37142655
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	4.43e-05	2	232	2	16493581
Pubmed	Tenascin-C affects invasiveness of EGFR-mutated lung adenocarcinoma through a putative paracrine loop.	TNC EGFR	4.43e-05	2	232	2	36878305
Pubmed	Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate.	ANXA2 ANXA2P2	4.43e-05	2	232	2	23148505
Pubmed	Setd5, but not Setd2, is indispensable for retinal cell survival and proliferation.	SETD2 SETD5	4.43e-05	2	232	2	36349512
Pubmed	Activation of EGFR-KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma.	KLF4 EGFR	4.43e-05	2	232	2	31465134
Pubmed	The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats.	ANXA2 ANXA2P2	4.43e-05	2	232	2	3013423
Pubmed	MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.	EGFR MUC4	4.43e-05	2	232	2	24582898
Pubmed	Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.	EGFR VCAN	4.43e-05	2	232	2	21079779
Pubmed	HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis.	HUWE1 EGFR	4.43e-05	2	232	2	32017279
Pubmed	Localization of annexin II in the paranodal regions and Schmidt-Lanterman incisures in the peripheral nervous system.	ANXA2 ANXA2P2	4.43e-05	2	232	2	17549680
Pubmed	Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice.	ANXA2 ANXA2P2	4.43e-05	2	232	2	39384746
Pubmed	Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.	ANXA2 ANXA2P2	4.43e-05	2	232	2	19841537
Pubmed	Cell adhesion and EGFR activation regulate EphA2 expression in cancer.	EGFR EPHA2	4.43e-05	2	232	2	19948216
Pubmed	Oxysterol-binding protein related-proteins (ORPs) 5 and 8 regulate calcium signaling at specific cell compartments.	OSBPL5 OSBPL8	4.43e-05	2	232	2	29748134
Pubmed	A phylogenetic study of SPBP and RAI1: evolutionary conservation of chromatin binding modules.	TCF20 RAI1	4.43e-05	2	232	2	24205348
Pubmed	RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.	URB1 RPTOR	4.43e-05	2	232	2	31886628
Pubmed	The c-Jun-induced transformation process involves complex regulation of tenascin-C expression.	JUN TNC	4.43e-05	2	232	2	9154819
Pubmed	Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer.	F3 EPHA2	4.43e-05	2	232	2	27246245
Pubmed	Expression of the Robo4 receptor in endothelial cells is regulated by two AP-1 protein complexes.	JUN ROBO4	4.43e-05	2	232	2	26459591
Pubmed	Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism.	SIRT2 EGFR	4.43e-05	2	232	2	34068624
Pubmed	Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis.	ANXA2 ANXA2P2	4.43e-05	2	232	2	22185818
Pubmed	EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis.	USP24 EGFR	4.43e-05	2	232	2	27991932
Pubmed	High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.	TNC ANXA2	4.43e-05	2	232	2	31463696
Pubmed	A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.	ANXA2 ANXA2P2	4.43e-05	2	232	2	21486955
Pubmed	Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene.	JUN TCF20	4.43e-05	2	232	2	8663478
Pubmed	Regulation of the low-dose radiation paracrine-specific anchorage-independent growth response by annexin A2.	ANXA2 ANXA2P2	4.43e-05	2	232	2	19580511
Pubmed	EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.	EGFR EPHA2	4.43e-05	2	232	2	21516087
Pubmed	Lhx4 surpasses its paralog Lhx3 in promoting the differentiation of spinal V2a interneurons.	LHX4 LHX3	4.43e-05	2	232	2	38970652
Pubmed	Selenomethionine promotes ANXA2 phosphorylation for proliferation and protein synthesis of myoblasts and skeletal muscle growth.	ANXA2 ANXA2P2	4.43e-05	2	232	2	36739096
Pubmed	Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.	ANXA2 ANXA2P2	4.43e-05	2	232	2	22517898
Pubmed	Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway.	ANXA2 ANXA2P2	4.43e-05	2	232	2	30462534
Pubmed	Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.	ANXA2 ANXA2P2	4.43e-05	2	232	2	21572519
Pubmed	Expression analysis of alpha-NAC and ANX2 in juvenile myelomonocytic leukemia using SMART polymerase chain reaction and "virtual Northern" hybridization.	NACA ANXA2	4.43e-05	2	232	2	12699894
Pubmed	Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development.	LHX4 LHX3	4.43e-05	2	232	2	15567726
Pubmed	Regulation of serum response factor activity and smooth muscle cell apoptosis by chromodomain helicase DNA-binding protein 8.	SRF CHD8	4.43e-05	2	232	2	20739623
Pubmed	ANNEXIN A2 FACILITATES NEOVASCULARIZATION TO PROTECT AGAINST MYOCARDIAL INFARCTION INJURY VIA INTERACTING WITH MACROPHAGE YAP AND ENDOTHELIAL INTEGRIN Β3.	ANXA2 ANXA2P2	4.43e-05	2	232	2	37832154
Pubmed	Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice.	ANXA2 ANXA2P2	4.43e-05	2	232	2	30902828
Pubmed	Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts.	JUN SMAD7	4.43e-05	2	232	2	15579469
Pubmed	Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.	ANXA2 ANXA2P2	4.43e-05	2	232	2	32687500
Pubmed	Agents that bind annexin A2 suppress ocular neovascularization.	ANXA2 ANXA2P2	4.43e-05	2	232	2	20607799
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	4.43e-05	2	232	2	15073129
Pubmed	A new role for host annexin A2 in establishing bacterial adhesion to vascular endothelial cells: lines of evidence from atomic force microscopy and an in vivo study.	ANXA2 ANXA2P2	4.43e-05	2	232	2	31253864
Pubmed	Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.	ANXA2 ANXA2P2	4.43e-05	2	232	2	19628708
Pubmed	Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.	ANXA2 ANXA2P2	4.43e-05	2	232	2	20847146
Interaction	TOP3B interactions	TANC2 HIVEP2 GBF1 PCNX3 OBSCN PEX6 TNRC6B JADE1 ZNF236 KLF4 JAK3 JUN LARP4B URB1 WIZ NUAK1 RPTOR OSBPL5 PKD1 UNKL SNX15 HERC2 MEX3B SEMA4F SEMA4B FLNC GRWD1 BICRA CHD8 FRYL NUP214 TNRC6C HUWE1 MED13L PKMYT1 ACTR1B SIRT2 MTMR14 ARVCF SETD5 ZNF335 CHD5 PUM1 DCAF4 RAI1 SMAD7	2.17e-10	1470	228	46	int:TOP3B
GeneFamily	Fibronectin type III domain containing	EPHB3 IL12RB1 OBSCN CNTN6 PTPRZ1 CNTN5 IGSF9 ROBO4 TNC EPHA2 IL6ST EPHA10	9.89e-09	160	151	12	555
GeneFamily	CD molecules\|Mucins	MUC17 MUC19 MUC16 MUC4	2.51e-05	21	151	4	648
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB3 EPHA2 EPHA10	1.94e-04	14	151	3	1095
GeneFamily	Clustered protocadherins	PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.95e-04	64	151	5	20
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA4F SEMA4B SEMA4G	5.87e-04	20	151	3	736
GeneFamily	E2F transcription factors	E2F7 E2F3	1.88e-03	8	151	2	982
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	OBSCN FGD4 ALS2 ITSN2	2.26e-03	66	151	4	722
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	OBSCN CNTN6 CNTN5 IGSF9 ROBO4 PALLD	2.34e-03	161	151	6	593
GeneFamily	Anoctamins	ANO4 ANO7	2.98e-03	10	151	2	865
GeneFamily	LIM class homeoboxes	LHX4 LHX3	4.33e-03	12	151	2	522
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL5 OSBPL8	4.33e-03	12	151	2	670
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL12RB1 IL17RB IL6ST	5.17e-03	42	151	3	602
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ARMCX4 ARVCF ARMC5	5.52e-03	43	151	3	409
Coexpression	NABA_ECM_AFFILIATED	FREM2 MUC17 SEMA4F SEMA4B ANXA2 ANXA2P2 MUC19 MUC16 FREM3 SEMA4G MUC4	1.70e-07	158	231	11	MM17063
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	HIVEP2 NCK1 F3 JUN LARP4B NUAK1 UBR5 OSBPL8 USP24 CHD9 E2F3 FRYL MED13L SETD2 EGFR ITSN2 PUM1 G6PD	1.96e-07	466	231	18	M13522
Coexpression	NABA_ECM_AFFILIATED	FREM2 MUC17 SEMA4F SEMA4B ANXA2 MUC19 MUC16 FREM3 SEMA4G MUC4	2.89e-06	170	231	10	M5880
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	TANC2 KIF21B CADM3 JPH4 RUNDC3B SLCO3A1 HSPA12A FAT2 NUAK1 CNTN5 PCDH19 DIP2B LRATD1 MUC19 AMER3 TNRC6C MED13L SEZ6L2 ZFHX4 VCAN CHD5 TENM1 FRMPD3 MAPK8IP2 RAI1 GABRA1	5.65e-06	1106	231	26	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP2 GBF1 NCK1 F3 JUN LARP4B NUAK1 UBR5 OSBPL8 SLC27A3 USP24 CHD9 E2F3 FRYL SPAG9 MED13L SETD2 IFRD1 EGFR ITSN2 PUM1 SMAD7	7.88e-06	856	231	22	M4500
Coexpression	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	IQSEC1 TCF20 BICRA USP24 TNRC6C SNX29 RAB3IP IL6ST SMAD7	8.64e-06	152	231	9	M2938
Coexpression	GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN	PER3 SUOX NIT1 SNX15 MACROD1 SEMA4G TNS1 G6PD GAA TMEM40	1.16e-05	199	231	10	M7510
Coexpression	GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN	KIF21B ZNF236 SNX15 HERC2 HSF1 USP24 FRYL TNRC6C RAB3IP SERAC1	1.21e-05	200	231	10	M9763
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING	KIF21B ZBTB22 SRF PEX6 KLF4 NUAK1 UNKL ELAC1 HEATR5B PHF21B ANO4 ANXA2 ANXA2P2 CHD8 FRYL AMER3 MED13L SEZ6L2 SEMA4G ZNF335 CHD5 DOCK7 SMAD7	1.36e-05	954	231	23	MM3689
Coexpression	GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP	RUNDC3B KLF4 IQSEC1 TCF20 COBLL1 FRYL ORAI3 IL6ST SMAD7	2.55e-05	174	231	9	M380
Coexpression	PASINI_SUZ12_TARGETS_DN	DOCK11 F3 BMP1 JUN NUAK1 FLNC ANXA2 ANXA2P2 VCAN PWWP3B DCBLD2 PALLD	3.26e-05	323	231	12	MM1066
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KIF21B GBF1 DOCK11 IL17RB USP24 FRYL SETD2 BAZ2A PWWP3B	3.32e-05	180	231	9	M8239
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL	CPAMD8 SLCO3A1 LMTK3 PLAAT4 MUC16 SEZ6L2 VCAN MUC4 RAI1 TMEM40	3.47e-05	226	231	10	M45709
Coexpression	LIU_PROSTATE_CANCER_DN	CPAMD8 SLCO3A1 ARMCX4 HEPH PER3 NHS NID1 FLNC ANXA2 ANXA2P2 WFDC1 EPHA2 TNS1 MUC4 PALLD	3.54e-05	493	231	15	M19391
Coexpression	ODONNELL_TFRC_TARGETS_UP	PTCRA NACA JUN PER3 OSBPL5 NID1 PLAAT4 WNT9A ZNF524 IFRD1 NIPAL2 ATP2B3 DCBLD2 PALLD	4.30e-05	443	231	14	M6753
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	TANC2 HIVEP2 HIC2 GMEB2 KLF4 HOXD1 PER3 PKD1 TCF20 BSDC1 SPAG9 MED13L SETD2 GTF2H1 BAZ2A SETD5 ITSN2 PUM1 PALLD KDM4B	4.46e-05	822	231	20	M6782
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	TANC2 HIVEP2 JUN FHIP1A COBLL1 SPAG9 MED13L IFRD1 PALLD IL6ST	5.76e-05	240	231	10	M39236
Coexpression	PEREZ_TP53_TARGETS	EPHB3 OBSCN HIC2 HSPA12A URB1 NUAK1 FGD4 WRAP73 IQSEC1 UNKL MEX3B FOXF2 ANO4 FLNC MACROD1 LHX3 TNRC6C MAGEE1 VCAN ITSN2 TNS1 GAA KDM4B TMEM40 SMAD7	6.43e-05	1201	231	25	M4391
Coexpression	BILD_CTNNB1_ONCOGENIC_SIGNATURE	LARP4B URB1 CHD9 FRYL VCAN KDM4B	7.14e-05	79	231	6	M7102
Coexpression	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP	HIVEP2 SRF GMEB2 WRAP73 SLC27A3 TCF20 SPAG9 ZNF335 RORC	7.24e-05	199	231	9	M8028
Coexpression	GSE27786_NKTCELL_VS_ERYTHROBLAST_DN	JPH4 PLA1A NID1 MED13L SEMA4G FEZF1 VCAN AGMAT MUC4	7.52e-05	200	231	9	M4867
Coexpression	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP	BMP1 WRAP73 SEMA4B LRATD1 WNT9A IFRD1 RAB3IP EMD IL6ST	7.52e-05	200	231	9	M8705
Coexpression	GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP	HIC2 NIT1 SNX15 GRWD1 ACTR1B LIMK1 GUSB EMD IL6ST	7.52e-05	200	231	9	M4093
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	HIVEP2 NCK1 FAT2 UBR5 USP24 CHD9 E2F3 FRYL MED13L PUM1 SMAD7	7.81e-05	300	231	11	M8702
Coexpression	PASINI_SUZ12_TARGETS_DN	DOCK11 F3 BMP1 JUN NUAK1 FLNC ANXA2 VCAN PWWP3B DCBLD2 PALLD	1.24e-04	316	231	11	M2293
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200	TNRC6B HOXD1 RPTOR FOXF2 SEMA4F LRATD1 NUP214 TENM4 ZFHX4 VCAN SERAC1	1.88e-06	166	228	11	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	HEBP2 HOXD1 FGD4 PTPRZ1 PCDH19 HERC2 ELAC1 MEX3B FOXF2 SEMA4F FAT4 COL17A1 TNC LRATD1 NUP214 TENM4 ZFHX4 EGFR SETD5 VCAN SERAC1 G6PD DCBLD2 IL6ST	6.73e-06	806	228	24	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	HOXD1 HERC2 ELAC1 FOXF2 SEMA4F FAT4 COL17A1 TNC LRATD1 ZFHX4 EGFR SETD5 VCAN SERAC1 DCBLD2 IL6ST	9.40e-06	408	228	16	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_100	HIVEP2 KLF4 ANO4 FAT4 LRATD1	1.10e-05	28	228	5	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200	HOXD1 FOXF2 SEMA4F COL17A1 TNC LRATD1 NUP214 ZFHX4 EGFR SERAC1	1.22e-05	165	228	10	gudmap_developingLowerUrinaryTract_e14.5_ urethra_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	TANC2 TNRC6B HOXD1 PTPRZ1 RPTOR HERC2 FOXF2 SEMA4F FAT4 COL17A1 LRATD1 NUP214 HUWE1 SEZ6L2 SEMA4G TENM4 ZFHX4 ARVCF SETD5 VCAN SERAC1 PUM1 IL6ST	2.62e-05	818	228	23	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#5	TANC2 F3 BMP1 COL17A1 TNC ANXA2 ANXA2P2 COBLL1 LRATD1 WNT9A EGFR RAI1 TMEM40	3.18e-05	309	228	13	ratio_EB_vs_SC_2500_K5
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500	SRF KLF4 F3 CNTN6 JUN FLNC MUC16 TENM4 PALLD	3.26e-05	148	228	9	gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000	SRF F3 CNTN6 JUN NUAK1 FLNC TNC MUC16 TENM4 EGFR VCAN PALLD GABRA1	3.40e-05	311	228	13	gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	MAP1A SRF F3 CNTN6 JUN NUAK1 MEX3B FLNC TNC MUC16 TENM4 VCAN PALLD	5.69e-05	327	228	13	gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200	FLNC MUC16 EGFR PALLD	6.71e-05	21	228	4	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	HOXD1 FOXF2 SEMA4F COL17A1 TNC LRATD1 ZFHX4 EGFR VCAN	9.57e-05	170	228	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	TNRC6B RPTOR NUP214 TENM4 VCAN SERAC1	9.78e-05	69	228	6	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500	FOXF2 SEMA4F FAT4 TNC TNRC6C HUWE1 ZFHX4 EGFR	1.19e-04	137	228	8	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	HOXD1 FOXF2 SEMA4F FAT4 COL17A1 TNC LRATD1 NUP214 TNRC6C HUWE1 ZFHX4 EGFR VCAN SERAC1	1.38e-04	407	228	14	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000	TANC2 HEBP2 KLF4 ZNF469 PLA1A RPTOR HERC2 FOXF2 SEMA4F FAT4 COL17A1 LRATD1 NUP214 HUWE1 ZFHX4 SETD5 VCAN SERAC1 DCBLD2 IL6ST TMEM40	1.87e-04	811	228	21	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500	HIVEP2 DOCK11 KLF4 ELAC1 FAT4 LRATD1 ZFHX4 EGFR PWWP3B	2.05e-04	188	228	9	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_200	FOXF2 TNC ZFHX4 EGFR	2.16e-04	28	228	4	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	HEBP2 E2F7 KLF4 FREM2 NUAK1 PTPRZ1 FOXF2 SEMA4F FAT4 COL17A1 LRATD1 NUP214 TNRC6C MED13L ZFHX4 EGFR VCAN TENM1 DCBLD2 IL6ST	2.52e-04	769	228	20	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_200	HIVEP2 KLF4 ELAC1 ANO4 FAT4 LRATD1	2.55e-04	82	228	6	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_200	FOXF2 SEMA4F TNC ZFHX4 EGFR	2.58e-04	53	228	5	gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000	FOXF2 SEMA4F FAT4 TNC TNRC6C HUWE1 TENM4 ZFHX4 EGFR GABRA1	3.12e-04	243	228	10	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000	PTPRZ1 FOXF2 SEMA4F FAT4 HUWE1 TENM4 ZFHX4	3.20e-04	120	228	7	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1
CoexpressionAtlas	cerebral cortex	KIF21B CADM3 JPH4 MAP1A LMTK3 HSPA12A NUAK1 PTPRZ1 CNTN5 PCDH19 PHF21B ANO4 PCDHGC4 PRR36 PCDHGB1 PCDHGA10 PCDHGA7 CECR2 AMER3 MAGEE1 FREM3 SEZ6L2 CHD5 ADGRA1 HHIPL1 PAX7 FRMPD3 ATP2B3 MAPK8IP2 GABRA1	3.27e-04	1428	228	30	cerebral cortex
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100	HOXD1 FOXF2 SEMA4F LRATD1 ZFHX4 SERAC1	3.30e-04	86	228	6	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_500	FOXF2 SEMA4F FAT4 HUWE1 ZFHX4 TENM1	3.30e-04	86	228	6	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_500
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	KLF4 F3 BMP1 JUN PLA1A PCDH19 NID1 TNC IFRD1 ABCA6 EGFR VCAN DOCK7 DCBLD2	3.44e-04	445	228	14	GSM777043_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500	SRF CNTN6 FLNC MUC16 TENM4 VCAN PALLD	4.09e-04	125	228	7	gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200	FREM2 FLNC MUC16 PALLD	4.15e-04	33	228	4	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_200
CoexpressionAtlas	placenta	CADM3 BMP1 CNTN5 HACE1 DLX4 GCM1 WFDC1 TRIM64 TRIM64B EGFR VCAN TMEM40	4.15e-04	349	228	12	placenta
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	HEBP2 HOXD1 IGSF9 FOXF2 SEMA4F FAT4 COL17A1 TNC LRATD1 NUP214 TNRC6C HUWE1 SEMA4G TENM4 ZFHX4 EGFR VCAN SERAC1 IL6ST GABRA1	4.60e-04	806	228	20	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#4_top-relative-expression-ranked_500	E2F7 SLCO3A1 PCDH19 SEMA4F	4.66e-04	34	228	4	gudmap_developingKidney_e15.5_Peripheral blastema_500_k4
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_500	CNTN6 FLNC TNC MUC16 TENM4 PALLD	5.02e-04	93	228	6	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	TANC2 HEBP2 HOXD1 FGD4 ALDH1L2 HERC2 ELAC1 FOXF2 SEMA4F FAT4 TCF20 TNC LRATD1 HUWE1 ZFHX4 SETD5 VCAN TENM1 IL6ST GABRA1	5.53e-04	818	228	20	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	CNTN6 HSPA12A NUAK1 FLNC TNC MUC16 TENM4 EGFR VCAN TNS1 PALLD	5.54e-04	310	228	11	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F3 JUN FAT2 PTPRZ1 IGSF9 SEMA4B COL17A1 TNC EGFR EPHA2 MUC4 TMEM40	6.48e-10	198	233	12	22935a8afac54021f68b5f7a5accf51523e2f336
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F3 FAT2 PTPRZ1 SEMA4B TNC ANXA2 LRATD1 EGFR EPHA2 MUC4 TMEM40	8.40e-09	198	233	11	89ec1e760a193441092571475cc66a3b425f232e
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN F3 FAT2 NUAK1 PTPRZ1 COL17A1 TNC TENM4 EGFR EPHA2 MUC4	8.40e-09	198	233	11	5374b0e98d669f36a0571d3c006c7bd5e3c8e87f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN F3 FAT2 NUAK1 PTPRZ1 COL17A1 TNC TENM4 EGFR TNS1 MUC4	8.86e-09	199	233	11	94a7867e800df352731796de8c24cba133c29622
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 F3 BMP1 FHIP1A CECR2 COBLL1 RNF220 TENM4 EGFR RORC	3.84e-08	179	233	10	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 NHS ANO4 SEZ6L2 SEMA4G SLC7A2 EGFR RAB3IP TENM1 FRMPD3	7.43e-08	192	233	10	bf1943715085c4124b1675888b0615c9500ec888
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HEBP2 F3 FAT2 SEMA4B TNC LRATD1 MUC16 EPHA2 MUC4 TMEM40	8.59e-08	195	233	10	24d226f89dd337c22728688e4b40ca082a0e1fe1
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMTK3 FAT2 PTPRZ1 SEMA4B TNC LRATD1 MUC16 EGFR MUC4 TMEM40	9.91e-08	198	233	10	9718f4c013c347f1b3c785ae232dd2fb6c1fe298
ToppCell	cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	F3 FAT2 PTPRZ1 SEMA4B TNC LRATD1 MUC16 EPHA2 MUC4 TMEM40	9.91e-08	198	233	10	6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	F3 FREM2 FAT2 PTPRZ1 SEMA4B TNC TENM4 EPHA2 MUC4 TMEM40	9.91e-08	198	233	10	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	F3 FAT2 PTPRZ1 SEMA4B COL17A1 TNC EGFR EPHA2 MUC4 TMEM40	1.04e-07	199	233	10	974f71b56f66243c78f2f297a1540e0e186df530
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F3 JUN FAT2 PTPRZ1 SEMA4B COL17A1 TNC EGFR MUC4 TMEM40	1.04e-07	199	233	10	4099df3c052a9536d72ba01492317be7d83a79ad
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HEBP2 F3 FAT2 PTPRZ1 TNC LRATD1 EGFR NIPAL2 PAX7 TMEM40	1.04e-07	199	233	10	ba284f984909504221900bca5ea12ada5b2ffd9f
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN F3 FAT2 PTPRZ1 SEMA4B COL17A1 TNC EGFR EPHA2 MUC4	1.09e-07	200	233	10	9da214f756a03516eaafde00289b90f69623b9f3
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LMTK3 F3 FAT2 PTPRZ1 TNC LRATD1 MUC16 EPHA2 MUC4 TMEM40	1.09e-07	200	233	10	ce969c958a31145bbfe315a9a865d7900ecc9549
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	F3 FAT2 PTPRZ1 SEMA4B COL17A1 TNC EGFR EPHA2 MUC4 TMEM40	1.09e-07	200	233	10	2a9d715aba8bdef2341b0d44ff60825c074a4b03
ToppCell	11.5-Airway-Epithelial-Basal_cell\|Airway / Age, Tissue, Lineage and Cell class	LMTK3 F3 CNTN6 PTPRZ1 PCDHGB1 LRATD1 MUC4 TMEM40 GABRA1	3.24e-07	172	233	9	9d4d92e2d16dfc8a394f2641653bb97de20a2530
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 F3 BMP1 PLA1A FHIP1A RNF220 TENM4 EGFR EPHA2	5.22e-07	182	233	9	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	FAT2 PTPRZ1 NHS COL17A1 EGFR EPHA2 PWWP3B TMEM40 GABRA1	5.46e-07	183	233	9	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 F3 BMP1 FHIP1A CECR2 RNF220 TENM4 EGFR RORC	6.26e-07	186	233	9	e83718fabb057100835d3357df407f283d23fe16
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	UPB1 FREM2 FOXI1 PRR36 LRATD1 MUC16 SEZ6L2 EGFR ADGRA1	6.84e-07	188	233	9	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM3 F3 BMP1 PLA1A NID1 FLNC ABCA6 VCAN DCBLD2	7.16e-07	189	233	9	0a8b827bba1efd885ad6c06929251c741dc3a541
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CADM3 SLCO3A1 BMP1 PLA1A NID1 FLNC EGFR VCAN DCBLD2	8.16e-07	192	233	9	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	F3 FAT2 PTPRZ1 NHS FHIP1A COL17A1 TNC EGFR EPHA2	8.16e-07	192	233	9	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	F3 FAT2 PTPRZ1 COL17A1 TNC ANXA2 EGFR MUC4 TMEM40	8.52e-07	193	233	9	7c34abdcb8839b9fb25457a79af6c5e7b9714b21
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NACA PTPRZ1 IGSF9 DLX4 COL17A1 TNC GCM1 TENM4 MUC4	9.28e-07	195	233	9	0be50d5bd0bef2240f7ace8056ce22a6ca2961b9
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 NHS ANO4 SEZ6L2 SEMA4G SLC7A2 EGFR RAB3IP TENM1	9.69e-07	196	233	9	7af6c5147ac859353504d19727dbe24f63a29dd4
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN FAT2 PTPRZ1 NHS DLX4 COL17A1 TENM4 EPHA2 MUC4	1.01e-06	197	233	9	1e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCell	3'-Broncho-tracheal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F3 FAT2 PTPRZ1 COL17A1 TNC EGFR EPHA2 MUC4 TMEM40	1.01e-06	197	233	9	5d33f8a6940431093e927b186fb9b630a89d8ec1
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NID1 PHF21B FOXF2 ANO4 FAT4 TENM4 ABCA6 VCAN PALLD	1.01e-06	197	233	9	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F3 FAT2 PTPRZ1 SEMA4B TNC EGFR EPHA2 MUC4 TMEM40	1.01e-06	197	233	9	233b9fcb376e08d0080a05ca0198ecc6ec720f90
ToppCell	3'-Broncho-tracheal-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F3 FAT2 PTPRZ1 COL17A1 TNC EGFR EPHA2 MUC4 TMEM40	1.05e-06	198	233	9	aa6e7218ee6230902854e66c444b544218b30c0e
ToppCell	21-Trachea-Epithelial-Basal_cell\|Trachea / Age, Tissue, Lineage and Cell class	KLF4 F3 JUN FAT2 PTPRZ1 SEMA4B ANXA2 LRATD1 EGFR	1.05e-06	198	233	9	6ed75b53030028be915a90c0bca4d12e471914a5
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JUN FAT2 PTPRZ1 SEMA4B COL17A1 TNC EGFR EPHA2 MUC4	1.10e-06	199	233	9	c88a28a73f54dc571f2ff1e4b55073f83cbead2c
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	F3 FAT2 PTPRZ1 COL17A1 LRATD1 EGFR EPHA2 MUC4 TMEM40	1.15e-06	200	233	9	c7668e26c6b8cfa6d174b0634e43c230425faba9
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SRF F3 FAT2 PTPRZ1 COL17A1 TNC EGFR EPHA2 TMEM40	1.15e-06	200	233	9	41705bbba40eb5ddca0b223191aac1bce00163b8
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Basal_2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	F3 FAT2 PTPRZ1 COL17A1 LRATD1 EGFR EPHA2 MUC4 TMEM40	1.15e-06	200	233	9	bce9bce9eb622bc6514708d49ca4a6604043c22a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN FAT2 PTPRZ1 NHS COL17A1 TENM4 EPHA2 MUC4 TMEM40	1.15e-06	200	233	9	8827653738a931e4a4545e0c7d75be12bed40740
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	F3 FAT2 PTPRZ1 SEMA4B TNC LRATD1 EPHA2 MUC4 TMEM40	1.15e-06	200	233	9	5f0f67958c9635db53e61f8370a92da6ea3e80fe
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	F3 FAT2 PTPRZ1 TNC LRATD1 SLC7A2 EGFR MUC4 PALLD	1.15e-06	200	233	9	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Basal_3\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	SRF F3 FAT2 PTPRZ1 COL17A1 TNC EGFR EPHA2 TMEM40	1.15e-06	200	233	9	53e04399d0308b40ae99fbfaa4ff62bf061822d8
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	F3 FAT2 PTPRZ1 COL17A1 LRATD1 EGFR EPHA2 MUC4 TMEM40	1.15e-06	200	233	9	621dd6438ef6e71811d3644b75209535b7c0f8f7
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SRF F3 FAT2 PTPRZ1 COL17A1 TNC EGFR EPHA2 TMEM40	1.15e-06	200	233	9	cc8df398532c9324fd3e171000b1ea5c208cd691
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	F3 FAT2 PTPRZ1 LRATD1 MUC16 SLC7A2 EGFR MUC4 PALLD	1.15e-06	200	233	9	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCDH19 NID1 FOXF2 FAT4 WFDC1 ABCA6 VCAN IL6ST	3.13e-06	169	233	8	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	368C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	GBF1 MAP1A PTCRA ZNF469 WIZ COBLL1 EPHA2 SNTA1	3.41e-06	171	233	8	f3bf5805823d5733b58742172e7668725ce82931
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OBSCN FAT2 CDC42BPG TNC MUC16 PKMYT1 EPHA2 MUC4	3.88e-06	174	233	8	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-basal_proximal\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	F3 FAT2 PTPRZ1 IGSF9 COL17A1 EPHA2 MUC4 GABRA1	4.59e-06	178	233	8	9534c4f4e950bb1498c1737ca1713e7f37d0aff2
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 OBSCN IL17RB SEMA4B TENM4 EGFR EPHA2 TNS1	4.99e-06	180	233	8	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	facs-Marrow-B-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 OBSCN IL17RB SEMA4B TENM4 EGFR EPHA2 TNS1	4.99e-06	180	233	8	82965ed1b72a1873c24dd4553d39681596057316
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 OBSCN IL17RB SEMA4B TENM4 EGFR EPHA2 TNS1	4.99e-06	180	233	8	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CADM3 SLCO3A1 BMP1 PLA1A PCDH19 ZNF35 ABCA6 VCAN	4.99e-06	180	233	8	c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	F3 BMP1 PLA1A FHIP1A COBLL1 RNF220 TENM4 EGFR	5.19e-06	181	233	8	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TANC2 HACE1 OSBPL5 CECR2 WDR91 RORC EMD DCBLD2	5.19e-06	181	233	8	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	F3 BMP1 PLA1A FHIP1A COBLL1 RNF220 TENM4 RORC	5.63e-06	183	233	8	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FREM2 FAT4 TENM4 ZFHX4 TENM1 EPHA10 OTOG	5.86e-06	184	233	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FREM2 FAT4 TENM4 ZFHX4 TENM1 EPHA10 OTOG	5.86e-06	184	233	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	DOCK11 ALDH1L2 OSBPL8 FAT4 MED13L ZFHX4 ABCA6 IL6ST	5.86e-06	184	233	8	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FREM2 FAT4 TENM4 ZFHX4 TENM1 EPHA10 OTOG	5.86e-06	184	233	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 F3 BMP1 FHIP1A CECR2 RNF220 TENM4 EGFR	5.86e-06	184	233	8	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CADM3 SLCO3A1 BMP1 PLA1A NID1 WNT9A VCAN DCBLD2	6.60e-06	187	233	8	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LDLRAD3 HEPH NHS PHF21B FOXF2 ANO4 TNC TENM4	6.60e-06	187	233	8	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	F3 FAT2 PTPRZ1 NHS FHIP1A COL17A1 EGFR MUC4	6.60e-06	187	233	8	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTN6 PTPRZ1 NHS ANO4 FAT4 SEZ6L2 EGFR VCAN	6.86e-06	188	233	8	6ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CADM3 BMP1 PLA1A NID1 FLNC ABCA6 HHIPL1 DCBLD2	6.86e-06	188	233	8	aa516273cdde53c8c0295f06830972388f890c97
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 F3 BMP1 PLA1A FHIP1A CECR2 TENM4 EGFR	6.86e-06	188	233	8	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM3 F3 PTPRZ1 SEMA4F ZFHX4 ARVCF TENM1 SNTA1	6.86e-06	188	233	8	921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	HEPH NHS PHF21B FOXF2 ANO4 FAT4 TNC TENM4	7.13e-06	189	233	8	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM3 F3 BMP1 PLA1A NID1 ABCA6 EGFR VCAN	7.13e-06	189	233	8	6e52cac679e0541ca5f2be316bdabdbc34da6e18
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	F3 PTPRZ1 NHS FHIP1A COL17A1 TNC EGFR EPHA2	7.41e-06	190	233	8	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	F3 BMP1 FREM2 FHIP1A COBLL1 SLC7A2 EGFR EPHA2	7.41e-06	190	233	8	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA1A NID1 CHD9 ZFHX4 ABCA6 EGFR VCAN PAX7	7.70e-06	191	233	8	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	18-Airway-Epithelial-Basal_cell\|Airway / Age, Tissue, Lineage and Cell class	F3 JUN PTPRZ1 IGSF9 COL17A1 LRATD1 TMEM40 GABRA1	8.31e-06	193	233	8	5067b0db24f96e26cf3f9437736415f694e7a614
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT2-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	FREM2 PCDH19 FHIP1A IL17RB PCDHGC4 LRATD1 IFRD1 EPHA2	8.63e-06	194	233	8	5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LDLRAD3 NHS NID1 TNC SLC7A2 ZFHX4 ABCA6 PALLD	8.96e-06	195	233	8	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MAP1A DOCK11 PTPRZ1 IQSEC1 FLNC COBLL1 WNT9A PALLD	9.30e-06	196	233	8	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	cellseq-Epithelial-Epithelial_Airway\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	F3 FAT2 PTPRZ1 TNC MUC16 EPHA2 MUC4 TMEM40	9.30e-06	196	233	8	faa39c567f24403e511b240c1d1a654ffadd8473
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LDLRAD3 NID1 FAT4 TNC ABCA6 VCAN DCBLD2 PALLD	9.30e-06	196	233	8	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LDLRAD3 NID1 FAT4 TNC ABCA6 VCAN DCBLD2 PALLD	9.30e-06	196	233	8	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CADM3 LDLRAD3 F3 JUN PTPRZ1 FLNC TNC PALLD	9.30e-06	196	233	8	45d1c0a962c4221c17393ee5566961d1deebf442
ToppCell	Bronchial_Biopsy-Epithelial-Basal_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	F3 JUN NUAK1 PTPRZ1 COL17A1 TNC EGFR TNS1	9.65e-06	197	233	8	a4855c5aebea4f0fed4eb035844572e82e5bac46
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	FAT2 PTPRZ1 NHS IGSF9 COL17A1 TNC EGFR TMEM40	9.65e-06	197	233	8	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TNC LRATD1 SLC7A2 TENM4 ZFHX4 EGFR VCAN PALLD	9.65e-06	197	233	8	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TNC LRATD1 SLC7A2 TENM4 ZFHX4 EGFR VCAN PALLD	9.65e-06	197	233	8	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JPH4 KLF4 JUN NUAK1 TENM4 ZFHX4 IL6ST GABRA1	9.65e-06	197	233	8	7c275a2ac24a9a4f83fceda93a067e754837102f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HEPH BMP1 HSPA12A NID1 SLC22A20P FOXF2 FAT4 COBLL1	9.65e-06	197	233	8	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TNC LRATD1 SLC7A2 TENM4 ZFHX4 EGFR VCAN PALLD	9.65e-06	197	233	8	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	F3 FAT2 PTPRZ1 PHF21B COL17A1 EGFR EPHA2 MUC4	9.65e-06	197	233	8	de772bd2b4cda843777ac879b1087e6444199dfb
ToppCell	21-Trachea-Epithelial-Club-like_secretory\|Trachea / Age, Tissue, Lineage and Cell class	HEBP2 KLF4 F3 ANXA2 MUC16 EPHA2 VCAN MUC4	1.00e-05	198	233	8	e735d82e5151c98b5724c543f8ad633c8ed824d2
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1A PTCRA JADE1 UNKL SEMA4B RUBCNL SNX29 SLX4	1.00e-05	198	233	8	d205dfcfe1f20e1e21bf84759e723d9e6e610a5c
ToppCell	Epithelial_cells-Basal_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	FAT2 NUAK1 PTPRZ1 IGSF9 COL17A1 TNC PALLD TMEM40	1.00e-05	198	233	8	4235005c49fc2b29ad3a0ee6b608f0109d04f775
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	F3 FAT2 PTPRZ1 SEMA4B COL17A1 TNC EGFR EPHA2	1.00e-05	198	233	8	fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A ZBTB22 HEPH LRRC14B NHS FLNC SEZ6L2	1.00e-05	142	233	7	67d4ff3483ae34f77c3325aa0fbd3462ca19ade4
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNC LRATD1 SLC7A2 TENM4 ZFHX4 EGFR VCAN PALLD	1.04e-05	199	233	8	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	proximal-Epithelial-Differentiating_Basal-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LMTK3 F3 FAT2 PTPRZ1 LRATD1 MUC16 MUC4 TMEM40	1.04e-05	199	233	8	c607346f60e5997e757e5a31cab412ab3734377b
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLCO3A1 NUAK1 NID1 TNC ABCA6 VCAN PALLD IL6ST	1.04e-05	199	233	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Biopsy_Control_(H.)-Epithelial-Basal\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	F3 FAT2 PTPRZ1 PHF21B FOXI1 COL17A1 EGFR GABRA1	1.04e-05	199	233	8	6a274a5db02c55bbf31d602b9d5c8394241acdca
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FAT2 PTPRZ1 COBLL1 CHD9 EGFR NIPAL2 TNS1 IL6ST	1.04e-05	199	233	8	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NUAK1 NID1 TNC ABCA6 VCAN TNS1 PALLD IL6ST	1.04e-05	199	233	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT2 PTPRZ1 NHS SEMA4B MUC16 TENM4 MUC4 TMEM40	1.04e-05	199	233	8	f5c3561744e2a0e7716657cb521acb1d8f054b41
Drug	Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A	CADM3 SRF JUN HSPA12A NID1 DLX4 EGFR BAZ2A EPHA2 PALLD SNTA1	3.58e-06	189	229	11	5675_UP
Drug	Cefoperazone dihydrate; Up 200; 5.8uM; HL60; HG-U133A	UPB1 HIVEP2 PTCRA F3 JUN CHD9 FRYL MED13L WDR91 KCTD3 KDM4B	4.83e-06	195	229	11	1627_UP
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A	KIF21B MAP1A PTCRA ZNF236 URB1 CNTN5 HSF1 HUWE1 BAZ2A PAX7 KDM4B	5.07e-06	196	229	11	4347_UP
Drug	2,4,4'-trichlorobiphenyl	KIF21B DOCK11 CYP27B1 E2F7 URB1 FAT2 HOXD1 FGD4 IGSF9 FHIP1A MEX3B IL17RB DIP2B ROBO4 CECR2 MACROD1 ALS2 FRYL AMER3 SNX29 PLEKHG6 ZFHX4 MTMR14 ARVCF RP1L1 DOCK7 NUP93 FRMPD3 CLSPN ATP2B3 GAA RAI1 GABRA1	5.32e-06	1411	229	33	ctd:C081766
Drug	Bemegride [64-65-3]; Up 200; 25.8uM; HL60; HT_HG-U133A	EPHB3 MAP1A PTCRA SRF HIC2 NID1 PLAAT4 SEMA4G BAZ2A CHD5 IL6ST	5.59e-06	198	229	11	3051_UP
Drug	2,4,5,2',5'-pentachlorobiphenyl	KIF21B DOCK11 CYP27B1 E2F7 URB1 FAT2 HOXD1 FGD4 IGSF9 FHIP1A MEX3B IL17RB DIP2B ROBO4 CECR2 MACROD1 ALS2 FRYL AMER3 SNX29 PLEKHG6 ZFHX4 MTMR14 ARVCF RP1L1 DOCK7 NUP93 FRMPD3 CLSPN ATP2B3 GAA RAI1	2.12e-05	1441	229	32	ctd:C009828
Drug	Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A	KIF21B GBF1 KLF4 JUN OAS2 MED13L PLEKHG6 BAZ2A IL6ST KDM4B	2.50e-05	191	229	10	5344_UP
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	HIVEP2 PTCRA JUN FOXI1 PCDHGA10 COBLL1 EGFR RORC IL6ST MAPK8IP2	2.73e-05	193	229	10	4410_DN
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	IL12RB1 MAP1A HSPA12A HOXD1 DLX4 PRR36 LHX3 ZFHX4 DCBLD2 SNTA1	2.86e-05	194	229	10	4169_DN
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	IL12RB1 SRF ZNF236 JUN PRR36 PCDHGA10 NUP214 NIPAL2 IL6ST MAPK8IP2	2.98e-05	195	229	10	5205_UP
Drug	Hexestrol [84-16-2]; Up 200; 14.8uM; HL60; HT_HG-U133A	TANC2 PTCRA TNC BICRA SEMA4G LIMK1 ZFHX4 ARVCF NIPAL2 MAPK8IP2	3.12e-05	196	229	10	2515_UP
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	TANC2 BMP1 JUN LARP4B IL17RB BICRA DALRD3 SEMA4G SETD2 DCAF4	3.12e-05	196	229	10	2072_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	EPHB3 TNRC6B HSPA12A WIZ HOXD1 DLX4 FOXI1 WDR91 ARVCF EPHA2	3.12e-05	196	229	10	3327_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	IL12RB1 BMP1 JUN LHX3 EGFR ARVCF NIPAL2 RORC ATP2B3 SNTA1	3.26e-05	197	229	10	5953_DN
Drug	Tyloxapol [25301-02-4]; Up 200; 4uM; HL60; HT_HG-U133A	WIZ DLX4 COL17A1 PLAAT4 PCDHGA10 COBLL1 HUWE1 SEMA4G CHD5 DCAF4	3.26e-05	197	229	10	3074_UP
Drug	Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	HIC2 TNC OAS2 DALRD3 SNX29 LIMK1 DCBLD2 SNTA1 IL6ST MAPK8IP2	3.26e-05	197	229	10	2752_UP
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	IL12RB1 GBF1 F3 JUN WIZ OAS2 RNF220 PLEKHG6 ZNF35 NIPAL2	3.26e-05	197	229	10	6233_UP
Drug	estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A	EPHB3 HIC2 PER3 IQSEC1 PCDHGA10 SEZ6L2 BAZ2A NIPAL2 PALLD KDM4B	3.40e-05	198	229	10	6200_UP
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	JAK3 WIZ HSF1 FOXF2 COL17A1 LIMK1 ARVCF TNS1 MUC4 KDM4B	3.40e-05	198	229	10	4316_UP
Drug	SureCN10139725	SRF JUN DLX4	3.41e-05	7	229	3	CID011765459
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; HL60; HT_HG-U133A	MAP1A PTCRA SRF BMP1 NUAK1 NID1 PCDHGA10 TNC LIMK1 DCAF4	3.55e-05	199	229	10	2483_UP
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	KIF21B PTCRA FAT4 TNC HUWE1 EGFR ARVCF BAZ2A VCAN SNTA1	3.55e-05	199	229	10	4957_UP
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; PC3; HG-U133A	CADM3 CYP27B1 TNRC6B F3 UBR5 E2F3 SPAG9 LIMK1 BAZ2A KDM4B	3.70e-05	200	229	10	1943_UP
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	GBF1 NACA SRF HIC2 JUN BAZ2A EPHA2 ZNF335 PUM1	4.86e-05	166	229	9	5324_UP
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A	CADM3 NACA HIC2 JUN EPHA2 ZNF335 PUM1 KDM4B SMAD7	5.33e-05	168	229	9	6087_UP
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	HIVEP2 LARP4B UBR5 CHD9 MED13L TENM4 ZFHX4 PUM1 KDM4B	6.12e-05	171	229	9	7535_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HG-U133A	HIC2 KLF4 F3 SPAG9 WDR91 TNS1 PALLD KDM4B RAI2	7.98e-05	177	229	9	1951_UP
Drug	WHI P180	JAK3 EGFR	1.01e-04	2	229	2	ctd:C118361
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A	IL12RB1 SRF HIC2 JUN FAT4 TNC BAZ2A EPHA2 ZNF335	1.03e-04	183	229	9	5677_UP
Drug	Mycophenolic acid [24280-93-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A	BMP1 URB1 HOXD1 UNKL FLNC COBLL1 ORAI3 RORC DCBLD2	1.12e-04	185	229	9	4137_UP
Drug	2-deoxy-D-glucose; Up 200; 10000uM; MCF7; HG-U133A	TANC2 NACA JUN SUPT7L SLC7A2 SETD2 IFRD1 ARVCF PALLD	1.17e-04	186	229	9	344_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 HIC2 WIZ PRR36 ZNF35 ARVCF EPHA2 KDM4B RAI2	1.37e-04	190	229	9	3966_DN
Drug	Sp 1 (pharmaceutical)	RUNDC3B SRF E2F7 KLF4 JUN DLX4 FOXI1 TCF20 PCDHGC4 PCDHGA10 MACROD1 PPOX SETD2 EGFR MUC4 SMAD7	1.47e-04	548	229	16	CID000099040
Drug	STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A	TNRC6B URB1 IL17RB COL17A1 GRWD1 LIMK1 TENM4 KCTD3 KDM4B	1.54e-04	193	229	9	6427_DN
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	MAP1A WIZ HSF1 NUP214 ARVCF RORC TNS1 DCBLD2 RAI2	1.60e-04	194	229	9	3363_UP
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A	MAP1A KLF4 HSPA12A WIZ PLA1A BICRA NUP214 VCAN ORAI3	1.60e-04	194	229	9	6660_DN
Drug	Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	CYP27B1 PEX6 KLF4 WIZ PLA1A FAT4 VCAN EMD DCAF4	1.60e-04	194	229	9	6647_DN
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	PEX6 HIC2 F3 IL17RB PLAAT4 TNC LIMK1 EGFR ORAI3	1.66e-04	195	229	9	5736_DN
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	HIC2 BMP1 WIZ PER3 SNX15 SEMA4F NUP214 ARVCF KDM4B	1.66e-04	195	229	9	1478_DN
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	IL12RB1 SLCO3A1 DLX4 FOXF2 PLAAT4 ARVCF BAZ2A TNS1 KDM4B	1.66e-04	195	229	9	5261_UP
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A	HIVEP2 JUN IQSEC1 SNX15 CHD8 SEZ6L2 ZFHX4 ITSN2 KLHL26	1.66e-04	195	229	9	1886_DN
Drug	Roxarsone [121-19-7]; Up 200; 15.2uM; HL60; HT_HG-U133A	IL12RB1 PTCRA PEX6 JAK3 HOXD1 PTPRZ1 TNC OAS2 PALLD	1.73e-04	196	229	9	2950_UP
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CADM3 IL12RB1 PTCRA NACA ZNF236 F3 HOXD1 NUP214 LIMK1	1.73e-04	196	229	9	1494_UP
Drug	Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; PC3; HT_HG-U133A	KIF21B UPB1 PTCRA KLF4 URB1 SEMA4F WDR91 EGFR TNS1	1.73e-04	196	229	9	3726_UP
Drug	Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	CADM3 UPB1 PTCRA SLCO3A1 TNC HUWE1 ARVCF VCAN TENM1	1.73e-04	196	229	9	3208_UP
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	SLCO3A1 WIZ FOXF2 PRR36 ZFHX4 NIPAL2 TNS1 KDM4B RAI2	1.73e-04	196	229	9	3637_DN
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	HIVEP2 PTCRA IQSEC1 COL17A1 COBLL1 NUP214 HUWE1 NIPAL2 KDM4B	1.73e-04	196	229	9	6169_UP
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A	CYP27B1 ZNF236 COBLL1 USP24 BSDC1 E2F3 VCAN ITSN2 AGMAT	1.80e-04	197	229	9	1826_UP
Drug	5194442; Down 200; 20uM; PC3; HT_HG-U133A	TANC2 NACA TNRC6B BMP1 SUPT7L DLX4 OAS2 TENM4 TNS1	1.80e-04	197	229	9	6594_DN
Drug	copper(II) sulfate pentahydrate; Up 200; 100uM; MCF7; HG-U133A	CADM3 BMP1 JUN HSPA12A WIZ RUBCNL SEZ6L2 PPOX LIMK1	1.80e-04	197	229	9	438_UP
Drug	Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A	PTCRA SLCO3A1 BMP1 WIZ SPAG9 PLEKHG6 SNTA1 IL6ST MAPK8IP2	1.80e-04	197	229	9	2260_DN
Drug	Iopanoic acid [96-83-3]; Up 200; 7uM; PC3; HT_HG-U133A	CADM3 PTCRA JAK3 BMP1 IL17RB NUP214 SEMA4G EGFR IL6ST	1.80e-04	197	229	9	6348_UP
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A	RUNDC3B PEX6 WIZ TNC OAS2 SEMA4G ZNF335 TNS1 ATP2B3	1.80e-04	197	229	9	5843_UP
Drug	Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	URB1 PER3 PCDHGA10 ARVCF TENM1 RORC SNTA1 KDM4B TMEM40	1.80e-04	197	229	9	2746_UP
Drug	Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A	SRF JADE1 KLF4 JUN BICRA BSDC1 ZNF335 NIPAL2 IL6ST	1.80e-04	197	229	9	2752_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	MAP1A SRF JADE1 JAK3 JUN PRR36 DALRD3 EPHA2 KDM4B	1.80e-04	197	229	9	7500_UP
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	OAS2 E2F3 SETD2 BAZ2A VCAN NIPAL2 TNS1 SNTA1 IL6ST	1.80e-04	197	229	9	4142_DN
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 F3 JAK3 URB1 WIZ FOXF2 TNC DALRD3 BAZ2A	1.80e-04	197	229	9	7523_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CADM3 LARP4B SUPT7L BICRA NUP214 SEMA4G ZFHX4 EGFR DCBLD2	1.80e-04	197	229	9	7177_UP
Drug	Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A	CADM3 PTCRA HIC2 HSPA12A PLAAT4 LHX3 SLC7A2 RORC RAI2	1.80e-04	197	229	9	4797_UP
Drug	Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A	CADM3 IL12RB1 PTCRA HEPH ROBO4 OAS2 ZFHX4 ARVCF SNTA1	1.80e-04	197	229	9	2812_UP
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; PC3; HT_HG-U133A	PTCRA HIC2 KLF4 JUN WIZ HSF1 PRR36 NUP214 RORC	1.87e-04	198	229	9	3721_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; MCF7; HT_HG-U133A	KIF21B IL12RB1 HSPA12A HOXD1 PER3 DLX4 EGFR EPHA2 SNTA1	1.87e-04	198	229	9	5434_UP
Drug	ST021200; Down 200; 10uM; MCF7; HT_HG-U133A	IL12RB1 TNRC6B JUN WIZ E2F3 NUP214 SIRT2 ARVCF RORC	1.87e-04	198	229	9	7554_DN
Drug	vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A	BMP1 PER3 SNX15 USP24 DALRD3 LIMK1 EGFR BAZ2A VCAN	1.87e-04	198	229	9	7517_DN
Drug	Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; PC3; HT_HG-U133A	CADM3 KLF4 PER3 HSF1 HUWE1 ARVCF BAZ2A NIPAL2 KDM4B	1.87e-04	198	229	9	4675_UP
Drug	Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A	F3 BMP1 HSPA12A WIZ HOXD1 IQSEC1 COBLL1 EGFR IL6ST	1.87e-04	198	229	9	6486_DN
Drug	chlorpropamide; Down 200; 100uM; MCF7; HG-U133A	PTCRA CYP27B1 ZNF236 WIZ FLNC BSDC1 NUP214 SEZ6L2 BAZ2A	1.87e-04	198	229	9	144_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A	SLCO3A1 HSPA12A PER3 IL17RB FOXI1 TNC COBLL1 HUWE1 TENM1	1.87e-04	198	229	9	5865_UP
Drug	Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A	HIVEP2 SRF KLF4 BICRA SPAG9 BAZ2A EPHA2 SMAD7 KLHL26	1.87e-04	198	229	9	2746_DN
Drug	AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A	SLCO3A1 LARP4B DLX4 GRWD1 PRR36 BICRA WDR91 ARVCF BAZ2A	1.87e-04	198	229	9	6587_DN
Drug	Pirlindole mesylate [60762-57-4]; Up 200; 12.4uM; HL60; HT_HG-U133A	TANC2 IL12RB1 KLF4 WIZ PER3 TNC CHD5 DCAF4 MAPK8IP2	1.87e-04	198	229	9	3140_UP
Drug	Methiazole; Up 200; 15uM; MCF7; HT_HG-U133A	CADM3 MAP1A ROBO4 COBLL1 LHX3 LIMK1 TENM4 TNS1 KDM4B	1.94e-04	199	229	9	3878_UP
Drug	Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	JUN URB1 HOXD1 COBLL1 NUP214 WDR91 EGFR NIPAL2 SNTA1	1.94e-04	199	229	9	2273_DN
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A	BMP1 URB1 DLX4 COL17A1 OAS2 LIMK1 BAZ2A TNS1 MAPK8IP2	1.94e-04	199	229	9	3287_UP
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	TANC2 JAK3 HOXD1 COL17A1 PLAAT4 LHX3 BAZ2A DCAF4 GABRA1	1.94e-04	199	229	9	2663_UP
Drug	nifedipine; Up 200; 10uM; MCF7; HG-U133A	GBF1 SLCO3A1 BMP1 JUN URB1 SUPT7L DLX4 BSDC1 IL6ST	1.94e-04	199	229	9	603_UP
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A	KIF21B CADM3 HIC2 HOXD1 FOXI1 SLC7A2 BAZ2A TNS1 SNTA1	1.94e-04	199	229	9	3265_UP
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	GBF1 HIC2 BMP1 WIZ BICRA E2F3 SETD2 BAZ2A IL6ST	1.94e-04	199	229	9	3435_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	IL12RB1 RUNDC3B ZNF236 WIZ FOXI1 PRR36 TNC EPHA2 DCBLD2	1.94e-04	199	229	9	5219_UP
Drug	Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A	CADM3 UPB1 PEX6 URB1 TNC EGFR VCAN CHD5 SNTA1	1.94e-04	199	229	9	5688_UP
Drug	FK-506; Down 200; 1uM; MCF7; HG-U133A	CADM3 ROBO4 NUP214 SEMA4G BAZ2A VCAN TNS1 SNTA1 KDM4B	1.94e-04	199	229	9	284_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A	CADM3 URB1 WIZ LIMK1 ZFHX4 EGFR TNS1 MUC4 DCAF4	1.94e-04	199	229	9	5992_UP
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	MAP1A URB1 DLX4 OAS2 NUP214 HUWE1 ARVCF MUC4 DCAF4	2.01e-04	200	229	9	4820_UP
Disease	Sarcosine measurement	PEX6 CNTN5 PCDHGB2 PCDHGB1 PCDHGA7	7.42e-07	23	225	5	EFO_0021668
Disease	childhood trauma measurement, alcohol consumption measurement	TANC2 OSBPL5 PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	1.20e-06	71	225	7	EFO_0007878, EFO_0007979
Disease	serum gamma-glutamyl transferase measurement	IL12RB1 UPB1 MAP1A PCNX3 DOCK11 NCK1 NUAK1 HACE1 PKD1 SEMA4B BICRA COBLL1 MACROD1 PERM1 CHD9 SEMA4G SETD2 TENM4 EPHA2 RP1L1 RORC DCAF4	2.25e-06	914	225	22	EFO_0004532
Disease	mental development measurement	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7	3.67e-05	25	225	4	EFO_0008230
Disease	Intellectual Disability	TANC2 HIVEP2 PEX6 IQSEC1 TCF20 E2F3 CHD8 MED13L SETD2 ZNF335 SERAC1 PUM1 RAI1	4.37e-05	447	225	13	C3714756
Disease	fish oil supplement exposure measurement, total cholesterol measurement	USP24 ABCA6	5.79e-05	2	225	2	EFO_0004574, EFO_0600007
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DIP2B SETD2 KDM4B	2.75e-04	17	225	3	DOID:0060307 (is_implicated_in)
Disease	Colorectal Neoplasms	CPAMD8 HOXD1 FLNC PPOX ABCA6 EGFR CHD5 IL6ST SMAD7	2.96e-04	277	225	9	C0009404
Disease	fish oil supplement exposure measurement, low density lipoprotein cholesterol measurement	USP24 ABCA6	3.44e-04	4	225	2	EFO_0004611, EFO_0600007
Disease	Orofacial cleft, alcohol consumption measurement	SLCO3A1 PAX7	3.44e-04	4	225	2	EFO_0007878, HP_0000202
Disease	Malignant Neoplasms	SRF HSF1 SETD2 EGFR EPHA2 G6PD	4.60e-04	128	225	6	C0006826
Disease	Amyotrophic Lateral Sclerosis, Familial	JAK3 HSF1 GABRA1 OTOG	4.92e-04	48	225	4	C4551993
Disease	Amyotrophic Lateral Sclerosis, Sporadic	JAK3 HSF1 GABRA1 OTOG	4.92e-04	48	225	4	C1862941
Disease	lung adenocarcinoma (is_implicated_in)	UBR5 IQSEC1 SETD2 EGFR	5.33e-04	49	225	4	DOID:3910 (is_implicated_in)
Disease	Combined pituitary hormone deficiencies, genetic form	LHX4 LHX3	5.70e-04	5	225	2	cv:C4273747
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	JAK3 HSF1 GABRA1 OTOG	5.76e-04	50	225	4	C1862939
Disease	Neurodevelopmental Disorders	TANC2 TNRC6B MED13L SETD2 SETD5	7.43e-04	93	225	5	C1535926
Disease	amino acid measurement	TANC2 E2F7 PER3 CNTN5 FAT4 COBLL1 LRATD1 PKMYT1 RNF220 SLC7A2 TENM4 VCAN RP1L1 AADAT	7.64e-04	678	225	14	EFO_0005134
Disease	response to iloperidone	SLCO3A1 PALLD	8.51e-04	6	225	2	GO_0036287
Disease	mean platelet volume	HIVEP2 PCNX3 PTCRA DOCK11 NACA FGD4 NID1 SEMA4F PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7 CHD9 FRYL SETD2 BAZ2A DOCK7	8.86e-04	1020	225	18	EFO_0004584
Disease	CHARGE syndrome (implicated_via_orthology)	CHD9 CHD8	1.19e-03	7	225	2	DOID:0050834 (implicated_via_orthology)
Disease	panhypopituitarism (is_implicated_in)	LHX4 LHX3	1.19e-03	7	225	2	DOID:9410 (is_implicated_in)
Disease	triglycerides to total lipids in medium VLDL percentage	COBLL1 ABCA6 ZNF335 DOCK7	1.38e-03	63	225	4	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	COBLL1 ABCA6 ZNF335 DOCK7	1.38e-03	63	225	4	EFO_0022239
Disease	cholangiocarcinoma (is_marker_for)	ANXA2 WNT9A MUC16 MUC4	1.46e-03	64	225	4	DOID:4947 (is_marker_for)
Disease	cholesteryl esters to total lipids in medium VLDL percentage	COBLL1 ABCA6 ZNF335 DOCK7	1.46e-03	64	225	4	EFO_0022253
Disease	neuroimaging measurement	KIF21B TNRC6B F3 ZNF469 NUAK1 PKD1 IGSF9 DIP2B FRYL ACTR1B EGFR VCAN NIPAL2 PAX7 TNS1 KDM4B RAI1 CRTC2	1.49e-03	1069	225	18	EFO_0004346
Disease	Malignant mesothelioma	HEPH SEMA4F ANXA2 SETD2 EGFR	1.51e-03	109	225	5	C0345967
Disease	Epileptic encephalopathy	NUP214 KCTD3 GABRA1	1.53e-03	30	225	3	C0543888
Disease	Malignant neoplasm of breast	OBSCN F3 CNTN6 BMP1 JUN PER3 NHS HERC2 WFDC1 NUP214 MAGEE1 SETD2 EGFR CHD5 ITSN2 TENM1 CLSPN TNS1	1.57e-03	1074	225	18	C0006142
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	COBLL1 USP24 E2F3 ABCA6 ZNF335 DOCK7 NUP93	1.64e-03	222	225	7	EFO_0008317, EFO_0020943
Disease	lymphocyte count	GBF1 TNRC6B NCK1 LDLRAD3 ZNF469 CNTN5 MEX3B PCDHGC4 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA7 COBLL1 MACROD1 E2F3 MED13L SETD2 TENM4 EGFR ARVCF KDM4B RAI1	1.96e-03	1464	225	22	EFO_0004587
Disease	Coronavirus infectious disease (implicated_via_orthology)	EGFR MUC4	2.01e-03	9	225	2	DOID:0080599 (implicated_via_orthology)
Disease	atrial fibrillation	NACA CNTN5 BICRA PERM1 LHX3 ZFHX4 RAB3IP DCAF4 SMAD7	2.30e-03	371	225	9	EFO_0000275
Disease	free cholesterol to total lipids in large LDL percentage	COBLL1 MACROD1 ABCA6 DOCK7	2.50e-03	74	225	4	EFO_0022280
Disease	dilated cardiomyopathy (implicated_via_orthology)	SRF FLNC EGFR ORAI3	3.31e-03	80	225	4	DOID:12930 (implicated_via_orthology)
Disease	intracranial aneurysm (is_implicated_in)	PKD1 VCAN	3.63e-03	12	225	2	DOID:10941 (is_implicated_in)
Disease	thyroxine measurement	LHX3 SNX29 PWWP3B AADAT	3.78e-03	83	225	4	EFO_0005130
Disease	omega-6 polyunsaturated fatty acid measurement	PTCRA COBLL1 SLC7A2 ABCA6 ZNF335 DOCK7	4.14e-03	197	225	6	EFO_0005680
Disease	cholangiocarcinoma (biomarker_via_orthology)	TNC MUC4	4.27e-03	13	225	2	DOID:4947 (biomarker_via_orthology)
Disease	Infantile Severe Myoclonic Epilepsy	PCDH19 GABRA1	4.27e-03	13	225	2	C0751122
Disease	Connective Tissue Diseases	ZNF469 PKD1	4.27e-03	13	225	2	C0009782
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	COBLL1 USP24 E2F3 ABCA6 ZNF335 DOCK7 NUP93	4.30e-03	264	225	7	EFO_0008317, EFO_0020944
Disease	Proteinuria	NCK1 MUC16 GUSB	4.31e-03	43	225	3	C0033687
Disease	Gastric Adenocarcinoma	JAK3 EPHA2 EPHA10	4.90e-03	45	225	3	C0278701
Disease	Myopathy, Centronuclear, Autosomal Dominant	MYF6 MTMR14	4.96e-03	14	225	2	C1834558
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 FLNC	4.96e-03	14	225	2	DOID:898 (implicated_via_orthology)
Disease	triacylglycerol 48:4 measurement	ZNF236 TENM4	4.96e-03	14	225	2	EFO_0010407
Disease	renal cell carcinoma (biomarker_via_orthology)	ANXA2 ANXA2P2	4.96e-03	14	225	2	DOID:4450 (biomarker_via_orthology)
Disease	major depressive episode	CNTN5 FREM3 TENM4	5.54e-03	47	225	3	EFO_0007634
Disease	chenodeoxycholate measurement	SLC22A20P SMAD7	5.69e-03	15	225	2	EFO_0010471
Disease	response to varenicline, Nausea	SLCO3A1 ANO4	5.69e-03	15	225	2	EFO_0600052, HP_0002018
Disease	hepatic encephalopathy (biomarker_via_orthology)	G6PD GABRA1	5.69e-03	15	225	2	DOID:13413 (biomarker_via_orthology)
Disease	HbA1c measurement	CPAMD8 CYP27B1 SLCO3A1 CNTN5 DIP2B COBLL1 MACROD1 TNRC6C FREM3 DALRD3 G6PD RAI1	5.93e-03	675	225	12	EFO_0004541
Disease	gait measurement	ZBTB22 E2F3 SETD5 KDM4B GABRA1	5.97e-03	150	225	5	EFO_0007680
Disease	monocyte count	NCK1 FGD4 CNTN5 PKD1 CECR2 MACROD1 MED13L AGBL3 WDR91 SETD2 LIMK1 IFRD1 EGFR ARVCF GUSB VCAN ITSN2 KDM4B RAI1	6.19e-03	1320	225	19	EFO_0005091
Disease	Congenital total cataract	NHS EPHA2	6.47e-03	16	225	2	C0266539
Disease	polyunsaturated fatty acids to total fatty acids percentage	COBLL1 ZNF335 DOCK7	6.59e-03	50	225	3	EFO_0022303
Disease	Crohn's disease	KIF21B PER3 MUC19 C16orf96 RNF220 CHD5 DOCK7 RORC SMAD7	7.04e-03	441	225	9	EFO_0000384
Disease	cortical surface area measurement	TANC2 CPAMD8 PCNX3 TNRC6B ZNF469 NUAK1 SUOX PKD1 IGSF9 ANO4 PERM1 FRYL MED13L PKMYT1 EGFR VCAN RP1L1 PAX7 TNS1	7.49e-03	1345	225	19	EFO_0010736
Disease	pancreatic cancer (is_marker_for)	MUC16 MUC4 PALLD SMAD7	7.55e-03	101	225	4	DOID:1793 (is_marker_for)
Disease	gastroesophageal reflux disease	HIVEP2 VCAN ADGRA1 KLHL26	7.55e-03	101	225	4	EFO_0003948

Protein segments in the cluster

Peptide	Gene	Start	Entry
GTPAATFPRDSYSGD	AMER3	406	Q8N944
GSSSGNSSPEYPRKE	COL17A1	111	Q9UMD9
GTAGTSSVPELPGFY	DCAF4	56	Q8WV16
PGDNVLLDEPAYSGT	AADAT	131	Q8N5Z0
EPRDLYGVSSSGPLS	AGBL3	71	Q8NEM8
GEYGDSPVPTPRSSS	CHD8	2206	Q9HCK8
AGEPRPTYFISSTVG	ACTL7B	66	Q9Y614
EGPEPRDSPSYGSLS	ARVCF	191	O00192
SLSPGPEQKYETEGS	VCAN	1131	P13611
APVLPNGSYDGSSLV	CHD5	1006	Q8TDI0
GTPSGTAEPYDGTKA	BSDC1	106	Q9NW68
RSESPEPGYVVTSSG	ALS2	1461	Q96Q42
APEPVSGGLYGIDDT	BAZ2A	306	Q9UIF9
TPNGAPEGTTTEISY	BAZ2A	1621	Q9UIF9
FYGSTLLNSSVPPGE	ALDH1L2	266	Q3SY69
ASYIVSTGDETPGPA	CEACAM16	66	Q2WEN9
LTVSVSDNYGAPPGA	FAT4	436	Q6V0I7
EEAPPGSYVSGISAT	FAT4	486	Q6V0I7
LNGVIFPDPSGDSYT	ABCA6	381	Q8N139
YTLPDGSTLDVGPAR	ACTR1B	241	P42025
VTQPEGSDGSPALYS	ADGRA1	481	Q86SQ6
ISEGYATGPDDISPD	ARMC5	461	Q96C12
LSLEGDHSTPPSAYG	ANXA2	11	P07355
PESDGSEFSGTPLKY	ANO4	841	Q32M45
PVPSSSSTYHAIIGG	CADM3	321	Q8N126
SGPPEEVYSAGDSVL	BMP1	941	P13497
LSLEGDHSTPPSAYG	ANXA2P2	11	A6NMY6
SAREPPSENGTSIYG	SLC7A2	231	P52569
SVAAAYPLGLSPTTA	DLX4	26	Q92988
GSDPATLYGSSGVPE	CECR2	661	Q9BXF3
SPEELSSPAGISSDY	COBLL1	401	Q53SF7
PNSGVGPYTTDSARL	ARMCX4	736	Q5H9R4
PSYEQSCGGVEPSLT	ARRDC1	416	Q8N5I2
SLGLSFYAPPGEESE	ATP2B3	121	Q16720
GLQDSYPGPSLDAVA	C17orf113	501	A0A1B0GUU1
AGYGPPSSEVSATTK	CNTN5	956	O94779
SSPASPLLGGYTVLA	GMEB2	421	Q9UKD1
YISDVGPPGRSSLDN	NUP93	166	Q8N1F7
SGYSAEPAGTPLSEP	RAI1	486	Q7Z5J4
PPETLYDSGASVDSS	RAI2	356	Q9Y5P3
PDGYNPEAPSITSSG	RBM27	486	Q9P2N5
VLADLGSLEPSDGPY	PCDHGA7	671	Q9Y5G6
PGILATSPYPETDSA	RUBCNL	151	Q9H714
YALDLGSSPVPSSTA	RBSN	571	Q9H1K0
ASPTSPDLLGVYESG	RAB3IP	31	Q96QF0
GYLDDPTVPRGSTTA	G6PD	321	P11413
PYSSVEPGDLTFTEG	ITSN2	991	Q9NZM3
ISSDYELLSDPTPGA	JAK3	781	P52333
TGTAYEGFLSVPRPS	CDC42BPG	946	Q6DT37
PDSTYPTTTISQDGG	PAX7	306	P23759
PEGESPAGSATYREF	ORAI3	16	Q9BRQ5
ASVPGARETDYPAGE	SPAG9	796	O60271
VSPPEAEKRGSYGST	ANO7	71	Q6IWH7
EITAALSPGSSAYPS	CYP27B1	346	O15528
PDSGSFGVQTYELTP	PCDH19	156	Q8TAB3
ASEGGLPTLSTYPES	MUC16	1231	Q8WXI7
RVPTSGTGDPRYASE	MUC16	2976	Q8WXI7
VSAIGEPGEPTTYSS	MUC4	536	Q99102
LDAFTYGPSPATDGT	PTCRA	71	Q6ISU1
LKASLSAPGSEYGSP	KLF4	231	O43474
SAPGSEYGSPSVISV	KLF4	236	O43474
SEVGSPPSYSEALLD	LDLRAD3	251	Q86YD5
DSAVPATSGKVYGTP	MAP1A	791	P78559
AGRGTYGSEESPEPL	MED13L	1366	Q71F56
GVSPTGSPDAVVSYS	MAGEB6	66	Q8N7X4
PTGSPDAGVSGSKYD	MAGEB6	111	Q8N7X4
YEGPSTSVVPTPDEG	MAGEE1	181	Q9HCI5
PSNYVTEEGDSPLGD	NCK1	156	P16333
SGDTSSEGPAQVYLP	GRWD1	21	Q9BQ67
TLEGAYEPGAAPAAA	HOXD1	86	Q9GZZ0
STGEPSATAPRGVVY	HHIPL1	556	Q96JK4
DHPLPGSSLSTDYGS	MTMR14	541	Q8NCE2
YPGESIGQTSDISSP	HERC2	1066	O95714
PLGASYLGVPSDADS	HERC2	3346	O95714
SGGFSASLHSEPPVY	JUN	156	P05412
SYVEPGSGPFSESTI	HEBP2	91	Q9Y5Z4
ETGTSLDSPSAYPQG	IQSEC1	31	Q6DN90
TLGTTYPAETLSPGG	KIAA1109	4086	Q2LD37
TSGYVENISPAPGSE	FREM2	1111	Q5SZK8
DPPSADAGTDYVGIS	FREM2	2051	Q5SZK8
GDSEGATVQLTPYFP	IL17RB	241	Q9NRM6
PVGPDDTNSEYESGS	MAPK8IP2	321	Q13387
EDSPGVYENGLTPSE	JPH4	441	Q96JJ6
VYENGLTPSEGSPEL	JPH4	446	Q96JJ6
PSEYDSLPENSETGG	LARP4B	131	Q92615
GDSGYETETPFSPEG	LMTK3	791	Q96Q04
SLYAPDAVASSGPII	HSF1	251	Q00613
AATSPGREYAAPGTA	PER3	806	P56645
PGYADSDPTFSLSVD	PCNX3	1521	Q9H6A9
SSYDGTLDENIPPGT	FAT2	461	Q9NYQ8
SEYSTSGPLNTPEKG	MUC19	446	Q7Z5P9
SYNITVTATDGGSPP	PCDHGA10	421	Q9Y5H3
STGVELAPRSAEPGY	PCDHGA10	576	Q9Y5H3
SASDPDLGPNGRVSY	PCDHGB1	471	Q9Y5G3
ASDPDLGPSGQVSYS	PCDHGB2	476	Q9Y5G2
EVAEGSPLYPGSDGT	MYF6	26	P23409
EAPDGPASAYLADTT	PEX6	391	Q13608
GGADTYSVPSVLSPR	NID1	321	P14543
ASDSSYRTPGIGPVL	FGD4	151	Q96M96
PETLASTPDSGYSID	FRYL	891	O94915
GLPDGTPPSSEYETL	KIF21B	251	O75037
DGTCTVSYLPTAPGD	FLNC	1911	Q14315
PGPGSYENLSTGTRE	HACE1	411	Q8IYU2
LQGTSGPDPTTVYVD	DIP2B	1326	Q9P265
EPLPANSYIGDDGTS	KDM4B	741	O94953
SSGGGSKPSYEAIPE	NUP214	1256	P35658
DPSDPTYTSSLGGKI	EPHB3	786	P54753
SLVYPDTSLGLVPSG	LHX3	336	Q9UBR4
SDISTGSSVGYPDFP	LHX4	361	Q969G2
TYASTPDGEDPLLAS	LRRC14B	256	A6NHZ5
LNYSELPTGDPSGIE	LRATD1	11	Q96KN4
TATSYTPNLARGDPG	GABRA1	371	P14867
YSSPARSLGDTGITP	HSPA12A	21	O43301
PPADSGGRSDVTYSL	EPHA10	361	Q5JZY3
SSGPEPSYALSDNEG	PTPRZ1	921	P23471
ASDPDLGPSGNVTFY	PCDHGC4	266	Q9Y5F7
QLSSGSTPSPEVYAG	OAS2	491	P29728
VPVSAGGEGETSPYS	HUWE1	3411	Q7Z6Z7
GGEGETSPYSLEASP	HUWE1	3416	Q7Z6Z7
PGTDPYTAGLAAAAT	PUM1	436	Q14671
IGPDTPGYTVASSAQ	OBSCN	5416	Q5VST9
RSPNGESSSPDSGYL	PALLD	191	Q8WX93
GYSSPEPDIQDSSGS	OSBPL8	796	Q9BZF1
VPDDTSDSGYGTLIP	PLEKHG6	581	Q3KR16
GSKPYDGIPASEISS	EGFR	911	P00533
LDSPGAATEYSDPSV	CHD9	2301	Q3L8U1
ADVGSPGPYDDLEVS	FHIP1A	591	Q05DH4
TGELLDPCGYISPES	IL6ST	21	P40189
PDGGAFYTPETIDTA	HEATR5B	1506	Q9P2D3
SDVPSLVTFGGTPYT	KLHL26	306	Q53HC5
PSAPGAEQTAGSLLY	E2F3	86	O00716
SEPSSPYREEQGSGG	E2F7	426	Q96AV8
ASDGSPKGSSPESYI	DOCK11	436	Q5JSL3
GQLGTYTIASPPERS	DOCK7	1416	Q96N67
EILSPSYSAASIGPD	C16orf96	646	A6NNT2
SSYVAAPDSSRTPGL	UPB1	316	Q9UBR1
LDPEETAYPSLSGGN	CRTC2	291	Q53ET0
DPTSKSSGQGYEVVP	FRMPD3	596	Q5JV73
DDPEATYTTSGGKIP	EPHA2	766	P29317
TSLGPVSDFYTLPVG	GUSB	311	P08236
VELSYPDGSPAEGVT	CPAMD8	366	Q8IZJ3
SGDLLPPSASGVYSD	GCM1	276	Q9NP62
SSALTEGDYVPDSPA	CDK11A	386	Q9UQ88
YSGEDEPQLAPRGTS	CNTN6	796	Q9UQ52
IVDPAISSSGPAGSY	GAA	441	P10253
GYSDPSSFAEDGPEV	IFRD1	56	O00458
TVGPIAYGEPSASQA	MACROD1	226	Q9BQ69
YPDADSGSASGPRDL	IL12RB1	36	P42701
LTDLEQPGSPGYSTA	GBF1	306	Q92538
AVAAYATPASPASLG	DALRD3	101	Q5D0E6
TTRTYGEPESAGPSR	EMD	101	P50402
EISGTIPHGYRDSSP	DCBLD2	221	Q96PD2
TAYVSGGSPTSHPLV	FOXI1	286	Q12951
QVPVSGYLASAAGPS	BICRA	256	Q9NZM4
GYLASAAGPSEPVTL	BICRA	261	Q9NZM4
GEYSTILPPVSFGAT	SLC22A20P	481	A6NK97
PYLASSPSTSDGGTD	KCTD3	771	Q9Y597
EILTYPSAFGSITGP	NIT1	221	Q86X76
GPGSSFAVTLPEAYE	PERM1	571	Q5SV97
LGPEEDGFSLASPYS	PKD1	3446	P98161
YGSAEGGPTELTPAT	OTOG	1936	Q6ZRI0
GESVGSITQPLPSSY	OSBPL5	206	Q9H0X9
PISTYSEGSTPLTGV	MUC17	3096	Q685J3
GDYGPDSSSSPVPSS	FOXF2	306	Q12947
TYTAGGEASVPSPDG	MEX3B	341	Q6ZN04
GRASSLGTEPDPALY	FREM3	31	P0C091
GYVVSTDDPLGLPVS	FREM3	361	P0C091
APPVANSASYSELGG	HIC2	286	Q96JB3
NSASYSELGGTPDEP	HIC2	291	Q96JB3
EGLDGSFPAVIDYTP	RUNDC3B	206	Q96NL0
GLPYAESFGEVPSAT	SERAC1	256	Q96JX3
SIGPPGKSSIDDSYG	TNRC6C	1331	Q9HCJ0
YSPADAPLGSLENGT	SNX29	411	Q8TEQ0
SGPSKGSVPYDAELS	SNTA1	351	Q13424
DLGAPPSGTTSYSQD	SEMA4F	701	O95754
VTVPYGNSTAPGSAL	SLCO3A1	451	Q9UIG8
DVNGSCIETPYSPGS	TAAR8	16	Q969N4
RGVAPDSKTTGSSYP	TOGARAM2	1001	Q6ZUX3
SPEKLAGLASPSSGY	NHS	1011	Q6T4R5
DSAPPTEETAYGRSL	PWWP3B	76	Q5H9M0
PDSHSLSYGTLPDGS	NIPAL2	356	Q9H841
AYDTSPKAGVTGSEP	FEZF1	81	A0PJY2
LAPPSEYPGAGSSSV	PLAAT4	36	Q9UL19
ATSTPEELRGYDSGP	PRR36	1126	Q9H6K5
YPDGSSGPLKADDSV	HEPH	141	Q9BQS7
GYQSLSDSPPGSRVF	SEMA4B	786	Q9NPR2
VSTDSLAPFTGTPGY	SETD5	1306	Q9C0A6
AGIPDFRSPSTGLYD	SIRT2	91	Q8IXJ6
DELSPVSPTQGGYPS	TANC2	1821	Q9HCD6
APSSLAVSPDGTLYV	TENM1	1496	Q9UKZ4
DIDALDPAYAPGTGT	AGMAT	276	Q9BSE5
LSEPGVPAEGLSRSY	NUAK1	551	O60285
AEDPGPAYGDAQSLT	WIZ	856	O95785
AGAGPLPSSESKYEI	WRAP73	296	Q9P2S5
KEYDFGTQLPSSSPG	RNF220	161	Q5VTB9
EGYVESPDLGSPVSR	SEZ6L2	181	Q6UXD5
VRSGGSPLSPVIYDS	SEZ6L2	406	Q6UXD5
GIPQSPDDSDSSYGS	SUPT7L	376	O94864
IVSSGSEPPELGYVD	JADE1	116	Q6IE81
ESDAPGPVYAAASLA	URB1	2086	O60287
NYALPSPATTEGGSL	RPTOR	691	Q8N122
TTPAPTAGALYSGSE	SRF	66	P11831
GVPLLPDTSTFYGSL	ROBO4	571	Q8WZ75
PDTSTFYGSLIAELP	ROBO4	576	Q8WZ75
YTADTGLPPGLSSEL	SLX4	756	Q8IY92
SPSDSGQGSYETIGP	CLSPN	26	Q9HAW4
ITGLDPAGPEYTRAS	PLA1A	186	Q53H76
PSSEDPGVLGIVYDS	PPOX	336	P50336
TTEDGAEPLLCPSGY	WFDC1	146	Q9HC57
PLDEGYGISSVPSAS	GTF2H1	276	P32780
EAPAASTLGSYSLPG	ZNF35	81	P13682
PDAVPSSAETGGTNY	SMAD7	226	O15105
GYSLPPSPLISTEDG	ZFHX4	2661	Q86UP3
TPPAGAQGADTLTYT	RORC	136	P51449
TTPAGPTYDLLFLGT	SEMA4G	436	Q9NTN9
PAALASPLSSAGVAY	PHF21B	136	Q96EK2
PLGSRTPEQGASEGY	RP1L1	2356	Q8IWN7
GEASETLQSPGYDPS	PKMYT1	86	Q99640
VSAEVDGPVPGYLSS	SLC27A3	261	Q5K4L6
TNTSEGGYPEALSPL	TNS1	526	Q9HBL0
LYGDAPGEVVPSGES	TMEM40	116	Q8WWA1
EGGPTPAYLSQATEL	SNX15	261	Q9NRS6
SGLPPSTDFIVYLSG	TNC	1496	P24821
PLPREGSGGSTSDYV	USP47	156	Q96K76
SSPSFLLGSEVGQPY	TLE7	101	A0A1W2PR48
VSLYPSGGTGLETPD	TENM4	396	Q6N022
ISGTPELSEPGNTYE	SH2D7	406	A6NKC9
GAAYPSPTRGASAVV	ELAC1	11	Q9H777
SPGAATHDSLSDYGP	TCF20	966	Q9UGU0
ESTGSAGEPLYENSP	F3	116	P13726
VGAGATAEPPYTALA	IGSF9	986	Q9P2J2
KTAVPPLSEGDGYSS	SETD2	1831	Q9BYW2
EPGTLGSAASSYSPL	UNKL	511	Q9H9P5
YRASGVDTSPGPPDT	ZNF469	411	Q96JG9
YLPPVDSRSSSGFVG	USP24	1676	Q9UPU5
PSAAYFGLTGSEPLT	WNT9A	26	O14904
EPAGLPQGFTVTDTY	ZNF236	876	Q9UL36
LDSDPTGTAYGASIP	SUOX	321	P51687
GVPYTVSEGSAAGPE	ZNF524	91	Q96C55
DVSKGSLIYGFPPSS	TRIM64	421	A6NGJ6
TGSDDVFYPGTVGIP	HIVEP2	571	P31629
EGTSAPGTPYSEEPA	ZNF335	891	Q9H4Z2
SEYSLPSDATGPFVL	WDR91	641	A4D1P6
DVSKGSLIYGFPPSS	TRIM64B	421	A6NI03
LDDSGGPTPSSYAPS	ZBTB22	396	O15209
SDPYVTPGSVLGGTA	TNRC6B	1496	Q9UPQ9
TPAASSAGLIYIDPS	UBR5	1736	O95071
PAYTPSGEAGSSARQ	LIMK1	276	P53667
IKTDSYAGPDSAGPL	NACA	621	E9PAV3